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Abstract 
 
T lymphocyte numbers in the human body are kept constant by homeostatic 
mechanisms balancing cell gain and loss. These mechanisms eventually fail in HIV 
infection, which is characterized by progressive immune deficiency attributable to a 
slow but relentless depletion of CD4
+ T cells, the main viral targets. HIV infection is 
also associated with increased T cell turnover and a state of generalized immune 
activation. One of the fundamental questions in the field of HIV research is the 
relation between CD4
+ T cell depletion and immune activation. It has been suggested 
that the virus has a direct effect by killing CD4
+ T cells and increased T cell turnover 
reflects a homeostatic response to CD4
+ T cell depletion. Alternatively, chronic 
immune activation may lead to enhanced turnover of T cells by ongoing proliferation-
differentiation and cell death. In both cases, AIDS is the result of an exhaustion of the 
regenerative capacity of the immune system. 
 
To address these questions we examined the consequences of activated CD4
+ T cell 
killing in a virus-free mouse model. Immunodeficiency viruses are highly selective 
for activated/memory and regulatory CD4
+ T cells due to restricted expression of 
CCR5, the co-receptor for HIV and SIV, or CD134 (OX40, TNFRSF4), the cellular 
receptor for FIV. Activated CD4
+ T cells were depleted by conditional reactivation of 
diphtheria toxin gene mediated by Tnfrsf4-driven Cre recombinase expression. 
Conditional ablation of activated CD4
+ T cells resulted in accelerated turnover, with 
only a minimal apparent effect on their numbers, and was associated with a reduction 
in CD4:CD8 ratio and development of CD4
+ T cell immune deficiency, resembling 
HIV infection. Importantly, activated CD4
+ T cell killing also resulted in generalized   4
immune activation, including lymph node enlargement, B cell expansion, elevated 
serum levels of proinflammatory cytokines and increased turnover and activation of 
CD8
+ T cells, characteristic of HIV infection. CD8
+ T cell activation correlated with 
lack of regulatory CD4
+ T cell function and was prevented upon regulatory CD4
+ T 
cell reconstitution. 
 
We therefore propose a causal link between memory and regulatory T cell depletion 
and immune deficiency and immune activation, respectively. 
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1. Introduction 
 
 
1.1. Infection with HIV 
 
 
1.1.1. Introduction 
Acquired immunodeficiency syndrome (AIDS) was first described in 1981 in two 
papers in the New England Journal of Medicine. These papers described 
Pneumocystis carinii pneumonia in individuals with low CD4
+ T cell counts (Masur 
et al., 1981; Gottlieb et al., 1981). Two years later, the etiological agent of AIDS was 
isolated and shown to be a retrovirus, now known as human immunodeficiency virus 
type 1 (HIV-1) (Barre-Sinoussi et al., 1983). In 1986, a second retrovirus strain, 
known as HIV-2, was isolated from patients with AIDS from West Africa (Clavel et 
al., 1986). HIV-2 has approximately 40-60% homology with HIV-1, but the majority 
of infected people do not progress to disease and die of unrelated causes (Rowland-
Jones and Whittle, 2007; Leligdowicz et al., 2007).  
 
HIV-1 has spread rapidly and the HIV epidemic has become a major global health 
problem.  According to the global summary of the AIDS epidemic published by 
UNAIDS in December 2007, 33.2 million people worldwide are living with HIV and 
2.1 million died as a result of AIDS in that year. The situation is particularly serious   19
in Sub-Saharan Africa, where the same report states an adult prevalence of 5% 
(http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf).  
 
At present there is no cure for AIDS. Although highly active anti-retroviral therapy 
(HAART) - a combination of anti-retroviral drugs - can suppress HIV-1 replication 
and delay illness for many years, it does not clear the virus completely. Moreover, 
access to antiretroviral treatment is limited in many parts of the world and even when 
antiretroviral treatment is available, it is associated with serious side effects and 
problems with adherence to therapy. Although much research has been done in order 
to develop a vaccine against HIV-1, none of the candidate vaccines that have been 
tested in clinical trials has been successful. This highlights the necessity for more 
basic research to understand the complex relationship between HIV and the immune 
system. 
 
1.1.2. Origin of HIV strains 
HIV strains have evolved in multiple cross-species transmissions from simian 
immunodeficiency viruses (SIVs) that infect nonhuman primates in Africa. HIV-1 
evolved from a strain of  SIV of chimpanzee (Pan troglodytes troglodytes) (Gao et al., 
1999), whereas HIV-2 originated in SIV found naturally in sooty mangabey monkeys 
(Cercocebus atys) (Hirsch et al., 1989). 
 
SIVs do not appear to cause AIDS in their natural African host: infected sooty 
mangabeys, African green monkeys, mandrils, sun-tailed monkeys, just to mention a 
few, are free of clinical disease and have a normal life span (Hirsch, 2004). In 
contrast, several species of Asian macaques (Macaca spp), like the rhesus macaque   20
(Macaca mulatta), develop AIDS when infected with a common non-pathogenic virus 
of African sooty mangabeys, albeit in a relatively short time when compared to HIV 
infection in humans (Heeney et al., 2006). Nevertheless, SIV infection of macaques 
has provided a powerful experimental model system to study the pathogenesis of 
AIDS. Additionally, studies of the differences between non-pathogenic SIV infections 
as well as of the less pathogenic HIV-2 infection and HIV-1 infection have also 
provided important clues on the determinants of immune deficiency in HIV-1 infected 
humans. 
 
1.1.3. CD4
+ T cell depletion in HIV disease 
The major hallmark of HIV-1 infection is the progressive CD4
+ T cell destruction and 
subsequent loss of immune function, which manifests clinically as an increased 
susceptibility to opportunistic infections and tumours. What drives the loss of CD4
+ T 
cells in this infection is still unclear. 
 
Interestingly, idiopathic CD4
+ lymphocytopenia which is a rare immunodeficiency of 
unknown cause, clinically very much resembles HIV infection. Patients have 
persistently low CD4
+ T cell counts and experience opportunistic infections, 
autoimmune disease and hematologic malignancies (Bonilla and Geha, 2006). Thus, 
the immunodeficiency seen in HIV infection resembles the CD4
+ T cells primary 
immunodeficiencies (Carneiro-Sampaio and Coutinho, 2007). 
 
No human virus other than HIV-1 causes such extensive and unavoidable CD4
+ T cell 
loss. HIV-2 targets the same cells as HIV-1 (i.e. CD4
+ T cells ) and has the same 
capacity to infect and replicate as suggested by the fact that proviral loads of HIV-2   21
and HIV-1 infected patients at the same disease stage are similar (Popper et al., 2000). 
Nevertheless, HIV-2 does not usually cause high viremia or such severe CD4
+ T cell 
depletion. Another retrovirus that exhibits the same tropism for CD4
+ T cells, the 
human T cell leukemia/lymphotropic virus 1 (HTLV-1), results in CD4
+ T cell 
lymphocytosis rather than lymphopenia (Matsuoka and Jeang, 2007).  
 
1.1.4. Clinical stages of HIV disease 
The typical course of untreated HIV-1 infection can be artificially divided in distinct 
phases. Primary infection occurs via the mucosal (gastrointestinal or reproductive) or 
parenteral route and is often associated with a febrile illness and clinical signs of viral 
dissemination to lymphoid tissues, central nervous system and other sites and may last 
from a few days to 4 weeks and then subside. This stage is characterized by active 
viral replication and high viremia and a sharp drop in peripheral blood CD4
+ T cell 
counts (Fig. 1). Viral replication then falls concurrently with the appearance in 
circulation of virus-specific CD8
+ T cells (Koup et al., 1994). This lower viral load set 
point is predictive of the rate of progression to AIDS in untreated individuals: the 
higher the level, the worse the prognosis (Mellors et al., 1996).  
 
Recently it has been shown that very early after infection there is a rapid and dramatic 
depletion of mucosal-associated memory CD4
+ T cells, which is not reflected in blood 
cell counts (Brenchley et al., 2004; Mehandru et al., 2004). This is also observed in 
pathogenic (Mattapallil et al., 2005; Li et al., 2005) and non-pathogenic infections 
with SIV (Pandrea et al., 2007; Gordon et al., 2007; Milush et al., 2007). 
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Figure 1. Changes in plasma viral load, peripheral blood CD4
+ T cell counts and 
HIV-1 specific CD8
+ T cell counts in the course of a typical untreated HIV-1 
infection.   23
Following the acute infection, there is a partial rise in blood CD4
+ T cell counts and 
although there may be no further evidence of illness for the next decade, peripheral 
blood CD4
+ T cell counts slowly decline and viremia slowly rises (Fig. 1).   
 
Circulating antibodies to HIV antigens appear within a few weeks of infection, 
usually after viral levels have begun to fall to the steady-state level. Although some of 
these antibodies may have strong neutralizing activity, rapid viral escape is 
characteristic. 
 
This long clinically asymptomatic period is misleading, because HIV infection is not 
latent. The steady-state in CD4
+ T cell counts actually represents a balance between 
rapid cell depletion and powerful restoration within the immune system. Eventually, 
the regenerative capacity of the immune system becomes exhausted and CD4
+ T cell 
counts drop below a threshold of about 200 cells/µl, when opportunistic infections 
occur (Douek et al., 2003; Weiss, 2008). 
 
Despite 25 years of research and many important events in HIV immunology 
(reviewed in (Rowland-Jones, 2003)), the precise mechanisms responsible for the 
unrelenting decline of CD4
+ T cell function and number are still unclear. In healthy 
individuals there is a rigorous control of the number of T cells in the body, but in 
HIV-1 infection these dynamics are affected. It is thus crucially important to 
understand how CD4
+ T cells are regulated to be able to understand what is happening 
in HIV-1 infection.    24
1.2. Regulation of CD4
+ T cells 
 
1.2.1. Peripheral CD4
+ T cell subsets  
T cell progenitors are generated in the bone marrow and migrate to the thymus where 
they rearrange their T cell receptors (TCRs) and undergo a process of selection. The 
TCR is designed to recognise antigens on cell surfaces and ignore structures that are 
soluble or free-floating (such as virus particles outside infected cells). TCRs recognise 
small peptide fragments on cell surfaces, bound to major histocompatibility complex 
(MHC) molecules. T cells with TCRs specific for self antigen are deleted through a 
process of negative selection, whereas T cells with TCRs specific for foreign antigens 
are retained by positive selection. T cells that survive selection differentiate to either 
CD4
+ or CD8
+ mature T cells and are exported to peripheral lymphoid tissues.  
 
1.2.1.1. Naïve and memory CD4
+ T cells 
T cells that leave the thymus are called naïve (Fig. 2) because they have not yet 
encountered their cognate antigen, and are thus in a resting state. They have a diverse 
distribution of TCRs with specificities capable of recognizing a broad array of 
peptides bound to MHC molecules. 
 
Naïve T cells home to secondary lymphoid tissues (spleen, lymph nodes and Peyer’s 
patches) and migrate continuously from one lymphoid organ to another, via blood and 
lymph. Entry to lymph nodes and Peyer patches is highly specific and occurs through 
high endothelial venules (HEV).   25
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Schematic representation of peripheral CD4
+ T cell pools. Naïve CD4
+ 
T cells migrate from the thymus to the periphery. Upon encounter with antigen 
presented on the surface of MHCII molecules on antigen presenting cells, naïve cells 
differentiate into effector cells, some of which are selected to enter the memory pool 
once the infection is cleared. The memory pool is a heterogeneous population 
composed of central memory and effector memory cells. Regulatory T cells are a 
distinct lineage originated in the thymus, although under certain conditions they can 
also be induced in the periphery. 
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Naïve T cells express L-selectin (CD62L), chemokines (C-C motif) receptor 7 
(CCR7) and lymphocyte function-associated antigen 1 (LFA-1) which interact with 
molecules on HEV. This combination of molecules is uniquely found on HEV and is 
essential for efficient homing of naïve T cells in lymphoid tissues. In these organs, 
naïve T cells travel to the T cell areas in search of antigen presented by antigen 
presenting cells (APCs). Continuous migration of naïve T cells through secondary 
lymphoid tissues is thus highly important for allowing T cells to make rapid contact 
with antigens released from pathogens. 
 
When naïve lymphocytes in T cell areas of secondary lymphoid organs encounter 
their cognate antigen presented on the surface of specialized APCs they become 
activated, clonally expand and differentiate into effector lymphocytes that can migrate 
to B cell areas or to inflamed tissues where they mediate clearance of the pathogen.  
 
After resolution of the infection, 90%–95% of antigen-specific T cells die by 
programmed cell death, leaving behind a long-lived population of resting T cells, 
called memory T cells, which provide protection upon re-infection (Fig. 2). Memory 
T cells form the cellular basis of immunological memory which can last for decades 
and is dependent on cell division (Bellier et al., 2003).  
 
Memory T cells possess several properties crucial for their function, including higher 
frequencies than naïve precursors, the ability to rapidly reactivate upon antigen 
stimulation, the ability to survive and self-renew for long periods in the absence of 
cognate antigen and wide tissue distribution. Indeed, whereas only a minority of naïve   27
T cells can be found in peripheral sites as part of their recirculation (Cose et al., 
2006), memory cells can be found in virtually all tissues of the body (Reinhardt et al., 
2001; Stockinger et al., 2004). Importantly for HIV-1 pathogenesis, a large population 
of memory CD4
+ T cells resides in mucosal sites (particularly the lamina propria) 
(Paiardini et al., 2008). 
 
Naïve and memory CD4
+ T cells can be distinguished by expression of distinct 
surface markers. In mice, naïve cells express CD62L and low levels of CD44, 
whereas memory cells lose CD62L and gain high levels of CD44 expression. Other 
markers are transiently expressed by memory cells upon activation, such as CD25, 
CD69 and CD43. 
 
Memory T cells are heterogeneous in terms of both homing capacity and effector 
function and are classified as central memory (TCM) and effector memory T cells 
(TEM) (Sallusto et al., 1999). TCM cells home to lymph nodes and have limited effector 
function, but they proliferate and become effector cells upon secondary stimulation. 
By contrast, TEM cells are able to enter peripheral non-lymphoid tissues, can rapidly 
produce effector cytokines such as interferon-γ (IFN-γ) upon antigenic stimulation, 
but have limited proliferative capacity (Bouneaud et al., 2005; Lanzavecchia and 
Sallusto, 2005). It has been suggested that TCM cells act as memory stem cells, self 
renewing and at the same time continuously replenishing the TEM pool (Lanzavecchia 
and Sallusto, 2002). 
 
Although several models have been proposed, there is good evidence that T cells 
differentiate progressively according to a linear sequence: from naïve T cell to central   28
memory cell to effector memory cell. Lanzavecchia and Sallusto have proposed that 
these two memory populations result from survival of effector cells and intermediate 
cells generated in a primary infection that are arrested at different stages of 
differentiation. This progressive differentiation theory is based on the fact that these 
stages depend on the strength of antigenic and cytokine stimulation that a cell has 
received (Lanzavecchia et al., 2002).  
 
1.2.1.2. Regulatory CD4
+ T cells 
Naturally-occurring regulatory CD4
+ T cells originate in the thymus and migrate to 
the periphery as a different lineage of CD4
+ T cells (Fig. 2). They are called 
regulatory because they are committed to suppressing both physiological and 
pathological immune responses and are essential in establishing and maintaining self-
tolerance and immune homeostasis. In mice, depletion of regulatory CD4
+ T cells 
activates self-reactive T cell clones inducing widespread autoimmune/inflammatory 
diseases in otherwise normal animals. Humans suffering from IPEX 
(immunodysregulation, polyendocrinopathy and enteropathy X-linked) syndrome lack 
regulatory T cells and develop autoimmune diseases and severe allergies (Sakaguchi 
et al., 2006). 
 
Naturally-occurring regulatory CD4
+ T cells have several features that make them 
unique among other T cells. Most regulatory CD4
+ T cells are produced by the 
thymus as a functionally distinct and mature T cell subpopulation, i.e. they are already 
specialized for suppressive function even before antigen encounter. Their TCR 
repertoire is as broad and diverse as that of naïve cells but it is more self-reactive and   29
only partially overlapping with that of naïve T cells (at least in mice) (Sakaguchi et 
al., 2006). 
 
 Regulatory CD4
+ T cells do not produce proinflammatory cytokines upon antigenic 
stimulation and therefore do not cause harm to the host despite high self-reactivity. 
Finally, they potently suppress the activation, proliferation and/or effector function of 
other CD4
+ and CD8
+ T cells, and possibly NK cells, NK T cells, B cells and 
dendritic cells (DCs) (Sakaguchi et al., 2006). 
 
Regulatory CD4
+ T cells account for approximately 10% of peripheral CD4
+ T cells 
and most express the CD25 marker on the cell surface. Indeed regulatory CD4
+ T 
cells have an activated phenotype, with expression of a number of activation markers 
including cytotoxic T lymphocyte Ag 4 (CTLA-4), glucocorticoide induced tumor 
necrosis factor receptor related protein (GITR), CD134 and LFA-1. Regulatory CD4
+ 
T cells are also characterized by lower levels of the α chain of the IL-7 receptor 
(CD127) (Liu et al., 2006; Seddiki et al., 2006).  
 
The most reliable marker of regulatory CD4
+ T cells at present is however the 
expression of the transcription factor forkhead box P3 (FoxP3) (Hori et al., 2003; 
Fontenot et al., 2003; Khattri et al., 2003). It is becoming clear that FoxP3 can also be 
transiently expressed in peripheral naïve T cells without inducing suppressor function. 
It has been proposed that regulatory CD4
+ T cells lineage is rather determined by a 
high-order regulatory system that sustains high levels of FoxP3 (Hori, 2008). 
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In the mouse, it has been shown in a number of experimental settings that regulatory 
CD4
+ T cells can also be induced by antigen in the periphery. These cells are called 
adaptive regulatory CD4
+ T cells and are phenotypically and functionally 
indistinguishable from the thymus-derived naturally occurring regulatory CD4
+ T 
cells (Thorstenson and Khoruts, 2001; Cobbold et al., 2004; Apostolou and von 
Boehmer, 2004). However it is questionable whether these cells are generated in 
physiological situations. 
 
Regulatory CD4
+ T cells are not anergic but they have proliferative capacity in vivo. 
They expand when transferred into lymphopenic hosts (Annacker et al., 2001; Gavin 
et al., 2002) and in response to immunization (Walker et al., 2003). In normal 
unmanipulated mice, regulatory T cells are heterogeneous: some are quiescent while 
others are constantly cycling and have an activated phenotype (Fisson et al., 2003). 
For this reason, these subsets are sometimes called ‘naïve’ and ‘memory’ regulatory T 
cells, respectively. 
 
In humans it has been shown that regulatory T cells are highly proliferative but very 
susceptible to apoptosis resulting in a limited self-renewal capacity. It has been 
proposed that they are continuously recruited from the memory CD4
+ T cell pool 
(Vukmanovic-Stejic et al., 2006) and various studies showing homology of TCR 
repertoire strongly support this idea (Kasow et al., 2004; Scheinberg et al., 2007; 
Ebinuma et al., 2008; Vukmanovic-Stejic et al., 2006).  
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1.2.2. Lymphocyte homeostasis  
Lymphocyte homeostasis is the process by which appropriate numbers of 
lymphocytes are maintained. Indeed, except fluctuations during infection or stress and 
predictable age-related changes, the number of lymphocytes stays within a relatively 
narrow range (Grossman et al., 2004). Homeostatic regulation occurs to maintain total 
numbers of lymphocytes but also diverse subpopulations of lymphocytes.  
 
1.2.2.1. CD4
+ and CD8
+ T cell homeostasis 
CD4
+ T cells are key players in the adaptive immune system being involved in both 
cellular and humoral responses whereas CD8
+ T cells are involved in response to 
viruses and tumours. In mice, the number of CD4
+ and CD8
+ T cells is co-regulated, 
i.e., in the absence of either subset the other will compensate to achieve the same total 
number of T cells (Freitas and Rocha, 2000). In MHC-I
-/- and MHC-II
-/- or CD4
-/-  and 
CD8
-/- mice, the absence of either of the two T cell subsets can be compensated by the 
remaining subset and the total number of T cells remains similar to that of normal 
mice (Tanchot et al., 1997). 
 
Similarly, most people with primary MHC-II deficiency, also known as the Bare 
Lymphocyte Syndrome, have normal number of circulating total T cells, but the 
number of CD4
+ T lymphocytes is reduced (Reith and Mach, 2001). Conversely, 
patients with absence of CD8
+ T cells due to mutations in the CD8α gene display 
normal numbers of CD3
+ T cells (Calle-Martin et al., 2001). 
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With age, the CD4:CD8 ratio in mice is reduced. This reduction is due to oligoclonal 
expansion of CD8
+ T cells responding to environmental antigens (Callahan et al., 
1993) and it is therefore dependent on the health status of the mice. In contrast, mice 
kept in specific pathogen free (SPF) facilities, the CD4:CD8 ratio remains constant or 
even increases with time (Bourgeois et al., 2005). 
 
Similar to mice housed in conventional facilities, the ratio CD4:CD8 drops in ageing 
humans. This is often due to expansion of cytomegalovirus (CMV)-specific CD8
+ T 
cells (Khan et al., 2002). Interestingly, the changes seen in ageing humans show many 
common features with changes seen in untreated HIV-1 infected patients, for example 
drop in CD4:CD8 ratio, decreased thymic output and reduced naïve cell numbers 
(Appay and Rowland-Jones, 2002). 
 
1.2.2.2. Naïve and memory T cell homeostasis 
The maintenance of balanced naïve and memory compartments is critical for immune 
function: diverse naïve T cell repertoire ensures adequate responses against new 
pathogens while memory T cells respond rapidly on re-encountering the same 
pathogens (Ge et al., 2002). 
 
The size of the naïve T cell pool is much more dependent on the input of new thymus 
emigrants than the size of the memory pool (Freitas et al., 2000) and in normal mice 
naïve T cells divide infrequently (La Gruta et al., 2000).  
 
Pivotal studies on the kinetics of bromodeoxyuridine (BrdU) labelling of T cells in 
BrdU-treated mice have shown that memory cells have a much higher rate of division   33
(turnover) than naïve cells (Tough and Sprent, 1994) and the same has been 
confirmed in humans by using different methods such as ex vivo BrdU incorporation 
(Geginat et al., 2003), Ki67 expression (Champagne et al., 2001), and in vivo 
incorporation with deuterated glucose into DNA (Macallan et al., 2003; Macallan et 
al., 2004). 
 
The pools of naïve and memory T cells are maintained independently, at least in 
steady state conditions (Stockinger et al., 2004), implying that the generation of new 
memory cells  results in competition for survival with existing memory cells, but not 
with naïve T cells (Tanchot et al., 1997; Bourgeois et al., 2005). Consequently, the 
sensors for space must differ between naïve and memory cells, and these pools are 
often referred to as occupying distinct ‘niches’ (Freitas et al., 2000). 
 
Because naïve T cells depend on replenishment from the thymus, with ageing and 
thymic atrophy, their numbers are reduced. Memory cell numbers, on the other hand, 
are not reduced in ageing animals (Bourgeois et al., 2005). The naïve T cell pool in 
humans is thought to be less reliant on thymic function than in mice, and displays a 
certain degree of self-renewal capacity. As a result, numbers of  peripheral T cells in 
ageing humans decline less than in ageing mice (Goronzy and Weyand, 2005; Akbar 
et al., 2004).   
 
1.2.2.3. Lymphopenia driven proliferation 
T cell lymphopenia can occur after chemo- or radiotherapy or after certain infections, 
for instance transiently in measles (Okada et al., 2000) and highly virulent Influenza 
A infection (Tumpey et al., 2000) and chronically in HIV-1 infection.   34
 
In lymphopenic conditions, the requirements for homeostatic proliferation differ from 
those of an immune response. Indeed, both naïve and memory cells extensively divide 
in the absence of their nominal antigen (Jameson, 2002). Naïve CD4
+ and CD8
+ T 
cells that proliferate under these conditions convert to a memory-like phenotype and 
lose their naïve status (Murali-Krishna and Ahmed, 2000; Tanchot et al., 2001). 
Interestingly, although the existence of memory CD4
+ cells of broad repertoire 
efficiently inhibits proliferation/differentiation of naïve CD4
+ T cells, a memory 
population of similar size but with a repertoire of limited diversity fails to do so (Min 
et al., 2004).  
 
1.2.2.4. Shared resources: the niche effect  
One of the hypothesized mechanisms by which the homeostatic control of cell 
numbers is achieved is that lymphocyte populations must compete for survival signals 
and resources are limited. To avoid competition, exclusion and to maintain diversity, 
cell populations have different requirements for resources defining different 
‘ecological niches’ (Tanchot et al., 1997). 
 
The survival of naïve T cells requires continuous contact with self peptides bound to 
MHC molecules together with interleukin (IL)-7. In contrast, survival of memory T 
cells is less reliant on TCR ligation. At least for memory CD8
+ T cells, the turnover 
and survival is controlled mainly by cytokines, namely IL-7 which enhances survival, 
and IL-15, which mediates proliferation (Goldrath et al., 2002; Tan et al., 2002; 
Kieper et al., 2002). What controls turnover and survival of CD4
+ memory T cells is   35
not clear but IL-7 and IL-15 have also been implicated, as has been TCR signalling 
(Li et al., 2003; Seddon et al., 2003).   36
1.3. Selectivity of HIV/SIV/FIV for memory and regulatory CD4
+ 
T cells 
 
1.3.1. Cellular tropism of HIV and SIV 
The key event in the course of viral entry into a target cell is the interaction between 
the virus and its cellular receptor(s). Both viral cell tropism and pathogenicity are 
determined by the specificity of these interactions.  
 
The CD4 molecule is the primary cellular receptor for HIV-1 and HIV-2 (Dalgleish et 
al., 1984; Klatzmann et al., 1984). These viruses bind CD4, which causes a change in 
the viral entry proteins, allowing them to bind the co-receptor and enter the cell 
(Doms and Moore, 2000).  
 
HIV-1 predominantly uses two different major co-receptors: CCR5 (Alkhatib et al., 
1996; Deng et al., 1996; Dragic et al., 1996) and CXC chemokines receptor (CXCR4) 
(Feng et al., 1996). These are members of the family of seven-transmembrane 
spanning chemokines receptors. CCR5 is almost always the initial target co-receptor 
for naturally transmitted virus. However, in about 50% of HIV-infected individuals 
progressing to AIDS, CXCR4-using viruses emerge late in the course of disease 
(Scarlatti et al., 1997). These ‘X4’ strains are more virulent than the initial ‘R5’ 
strains and probably accelerate the depletion of CD4
+ T cells and the onset of disease. 
However, switch to CXCR4 is not necessary for disease progression. Certain variant 
strains are dual tropic and exhibit features of both groups. There are more than a   37
dozen of other minor co-receptors that HIV can use in vitro, but their significance in 
vivo is not clear (Clapham and McKnight, 2001). 
 
Accordingly, HIV mainly infects hematopoietic cells that express CD4 and CCR5 or, 
in late stages of disease of some individuals, CXCR4. It is interesting to note that a 
broader use of receptors and co-receptors would mean a wider cell tropism which 
could be advantageous for the virus. However HIV has not evolved variants capable 
of using alternative receptors/co-receptors. The factors that restrict the use of co-
receptors other than CCR5 and CXCR4 in vivo are not known (Clapham et al., 2001).  
 
CD4 is expressed predominantly in lymphocytes but can also be expressed by cells of 
the monocyte-macrophage lineage, dendritic cells and microglia cells in the brain.  
 
CCR5 is expressed in memory/activated and regulatory CD4
+ T cells (Bleul et al., 
1997; Oswald-Richter et al., 2004) and directs their migration along CCL3 
(macrophage inflammatory protein 1α- MIP-1α), CCL4 (MIP-1β) and CCL5 
(regulated upon activation, normal T cell expressed and secreted (RANTES)) 
gradients (Samson et al., 1996; Raport et al., 1996). CD4
+ CCR5
+ T cells are 
infrequent in the peripheral blood, lymph nodes and spleen but account for almost all 
CD4
+ T cells in other tissues including the mucosal surfaces of the intestine, 
respiratory and reproductive tract. CCR5 expression has also been reported (primarily 
from mouse studies) on multiple other cell types including macrophages, dendritic 
cells, neutrophils and hepatic stellate cells.  
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CXCR4 is more widely expressed in cells of both the immune, particularly by naïve T 
cells (Bleul et al., 1997) and the central nervous systems and regulates cell migration 
along gradients of stromal cell-derived factor-1 (SDF-1 or CXCL12) (Oberlin et al., 
1996; Bleul et al., 1996).  
 
The importance of CCR5 as primary co-receptor for the pathogenesis of AIDS is 
illustrated by the fact that individuals with polymorphisms in the CCR5 gene show 
increased resistance to HIV infection and/or slower disease progression (Michael, 
1999).  
 
Similar to HIV, primary SIV isolates use CD4 as the main receptor and mainly CCR5 
as co-receptor for host cell entry (Chen et al., 1998; Gautam et al., 2007). However, 
unlike HIV, co-receptor switching form CCR5 to CXCR4 has not been demonstrated 
in vivo for SIV. A switch from macrophage-tropism to lymphocyte tropism has been 
shown to be due not to co-receptor switching but to the way CCR5 is exploited as co-
receptor (Mori et al., 1992).  
 
1.3.2. Receptors for FIV 
FIV, the feline immunodeficiency virus, is the only non primate lentivirus that causes 
a disease similar to AIDS in its natural host species, the domestic cat (Pedersen et al., 
1987).  
 
The feline immunodeficiency syndrome is characterized by a progressive decline in 
the number of circulating CD4
+ T cells and an associated inversion of the CD4:CD8 
ratio, activated CD8
+ T cells, polyclonal B cell activation and   39
hypergammaglobulinemia (Willett et al., 1997b; Novotney et al., 1990). Clinical 
manifestations include wasting, neurological disturbances, chronic stomatitis and 
gingivitis and increased incidence of lymphoma.  
 
In contrast to HIV and SIV, however, FIV does not use CD4 as its viral receptor. The 
primary receptor for FIV is CD134 (or OX40) (Shimojima et al., 2004), a T cell 
activation antigen and co-stimulatory molecule. CXCR4 is the sole co-receptor for 
infection (Willett et al., 1997a) although with disease progression, the viral cell 
tropism becomes broader (English et al., 1993; Dean et al., 1996).  
 
CD134 is a member of the tumour necrosis factor receptor (TNFR) superfamily 
(TNFRSF4) (Watts, 2005). It is a co-stimulatory receptor that, unlike CD28, is not 
constitutively expressed on naïve CD4
+ T cells but is induced within 12-24 hours after 
antigen recognition, peaking at 48 hours and declining after 72 to 96 hours 
(Gramaglia et al., 1998). In regulatory CD4
+ T cells, expression of CD134 is 
constitutive (Takeda et al., 2004; McHugh et al., 2002). Although largely restricted to 
CD4
+ T cells, under conditions of strong antigenic stimulation, CD134 can also be 
induced in CD8
+ T cells (Baum et al., 1994). 
 
CD134 ligand is normally expressed on APCs such as B cells, dendritic cells, 
macrophages and endothelial cells when activated (Watts, 2005). 
 
Thus, although using different receptor/co-receptor combinations, all retroviruses that 
cause immunodeficiency predominantly target the same type of cells, i.e. 
activated/memory CD4
+ T cells and regulatory CD4
+ T cells (Fig. 3).    40
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Immunodeficiency viruses target memory and regulatory CD4
+ T cells. 
Viral cellular tropism is dictated by receptor/co-receptor usage: HIV and SIV use the 
broadly expressed CD4 molecule as receptor for host cell entry, while the specificity 
of the target cells is given by the more strictly expressed co-receptor, CCR5, which is 
solely expressed in activated/ memory and regulatory CD4
+ T cells. FIV, on the other 
hand, utilizes the broadly expressed co-receptor CXCR4. Specificity for target cells in 
this case is given by the usage of CD134 as receptor. 
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1.4. Pathogenesis of HIV/SIV infections 
Virtually every arm of the immune response is affected by HIV, but the precise 
mechanisms that lead to immune dysfunction are still poorly understood. While it is 
now clear that CD4
+ T cell numbers decrease because there is a failure to replenish 
them, what drives their loss in the first place is unclear.  
 
1.4.1. Tap and drain hypothesis 
Early studies done even before the HIV-1 receptor was discovered showed that 
infected CD4
+ T cells are directly killed by the virus, providing a logical explanation 
for the progressive decline of these cells in HIV-infected individuals (Ho et al., 1995; 
Wei et al., 1995). 
 
According to this ‘tap and drain’ model of CD4
+ T cell depletion, the rate of CD4
+ T 
cell destruction by HIV is too fast to be compensated for by natural CD4
+ T cell 
production by the immune system, ultimately resulting in CD4
+ T depletion (Ho et al., 
1995). 
 
The impact of HIV-1 on the human immune system could be solely explained by the 
crucial role CD4
+ T cells have in coordinating a range of immune functions. 
However, there was a discrepancy between the number of infected CD4
+ cells in the 
circulation and extend of T cell dysfunction. This issue was clarified when it was 
shown that HIV infected T cells are trapped in the follicular dendritic cells network in 
the lymph nodes (Spiegel et al., 1992). Indeed we now know that in the early stages of   42
infection 1,000-times more infected cells are present in lymphoid tissue that can be 
found in the blood (Pantaleo et al., 1993; Embretson et al., 1993). 
 
1.4.2. Immune activation hypothesis 
While some recent studies (Okoye et al., 2007) continue to indicate a role for viral 
destruction in CD4
+ T cell depletion, other important experimental observations 
suggest that factors others than (or in addition to) destruction by viral infection are 
responsible for CD4
+ T cell depletion in the setting of HIV-1 infection. 
 
It has been shown that during chronic HIV infection, more CD4
+ T cells die that can 
be accounted for by direct infection, and that, in fact, an increased death rate is 
observed in non-target cells, such as CD8
+ T cells (Finkel et al., 1995). This bystander 
loss of uninfected T cells is thought to be related to a state of generalized immune 
activation that is consistently associated with HIV infection.  
 
This immune activation is characterized by increased frequencies of B and T cells 
expressing activation markers and exhibiting a memory phenotype, increased plasma 
levels of proinflammatory  cyokines and increased turnover of T and B and NK cells 
and accessory cells (Grossman et al., 2006). 
 
Based on these findings, it has been proposed that chronic immune activation plays a 
key role in the HIV-associated CD4
+ T cell depletion. Consistent with this model is 
the finding that the expression of activation markers on T cells is a strong predictor of 
disease progression in HIV-infected individuals, independently of viral loads (Muro-
Cacho et al., 1995; Giorgi et al., 1999; Leng et al., 2001; Sousa et al., 2002).   43
 
Thus, HIV-associated chronic immune activation results in a constant recruitment of 
CD4
+ T cells from the central memory and naïve pools to the effector pool, thus 
creating a strain on the homeostatic mechanisms of CD4
+ T cell maintenance.  
 
The causes of this generalized immune activation are however not well understood. 
Possible proposed causes include HIV antigens and non-HIV antigens such as 
translocated microbial products and impairment of regulatory T cells. 
 
Recent studies have shown that HIV encodes single stranded RNA sequences that can 
directly activate the immune system via Toll-like receptor (TLR)7 and TLR8 (Meier 
et al., 2007). Another proposed cause of immune activation is based on the early 
direct cytopathic effects of HIV on the gastrointestinal tract CD4
+ T cells. As a 
consequence of the depletion of these cells, the integrity of the mucosa is 
compromised, which in turn allows commensal bacterial to leak into the circulation (a 
phenomenon known as microbial translocation) (Brenchley et al., 2007). Chronic 
immune activation may also be due to antigen processing during cell death. In HIV 
infection, CD4
+ T cells die predominantly by apoptosis - the process of programmed 
cell death. Excessive levels of T cell apoptosis in HIV-1 infection release protein 
fragments that trigger the formation of autoreactive CD8
+ T cells. These CD8
+ T cells, 
that would normally not be activated, undergo clonal expansion and are primed by 
cross-presenting APCs, which in turn cause more apoptosis and results in chronic 
immune activation (Rawson et al., 2007). Eventhough this may occur, it is known that 
apoptotic cells are cleared by macrophages. Finally, the susceptibility of regulatory T   44
cells to HIV infection (Oswald-Richter et al., 2004) may remove the control of 
excessive immune activation. 
 
The relationship between immune activation and progressive immune deficiency is 
supported by studies in non-human primates. Sooty mangabeys present high levels of 
SIV replication but manifests limited evidence of disease (Rey-Cuille et al., 1998). 
This lack of pathogenicity is accompanied by absence of the extensive immune 
activation and cellular proliferation that characterizes SIV infection of other primates 
such as the rhesus macaque, in which immune activation closely mimics the 
activation seen in HIV-infected humans (Chakrabarti et al., 2000). Moreover Sooty 
mangabeys seem to maintain thymic and bone marrow function and do not 
demonstrate bystander lymphocyte apoptosis (Silvestri et al., 2003).  
 
1.4.3. Diminished production 
Not only HIV-1 has an effect on CD4
+ T cell dynamics, but it is also responsible for 
alterations in the organs responsible for the primary production of these cells. Indeed 
late stages of HIV infection are often characterized by cellular hypoproductivity of the 
bone marrow, which is not limited to the CD4
+ T cells and leads to the pancytopenia 
that is often observed in advanced AIDS. The mechanisms responsible for this 
impairment of bone marrow productivity are not well understood but concurrent 
infections with opportunistic agents may play a role. Furthermore, hematopoietic 
progenitor cells in the bone marrow are susceptible to infection with HIV (Stanley et 
al., 1992) and their function is impaired (Marandin et al., 1996; Louache et al., 1992). 
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Although some studies show preservation of thymus size (particularly in older 
individuals) (McCune et al., 1998; Kalayjian et al., 2003) and suggest that thymic 
output is maintained in HIV infected individuals (Zhang et al., 1999), there is also 
evidence that HIV can infect thymic stromal cells and that HIV strains that use 
CXCR4 co-receptor can infect thymocytes as well (Berkowitz et al., 1998).    46
1.5. Mouse tools 
Genetic manipulations of the mouse genome, such as random integration of 
transgenes or homologous recombination in embryonic stem cells, are widely used 
and have been instrumental for the understanding of gene function. These 
technologies allow the introduction of a permanent genetic alteration in the mouse 
germ line, but they do not allow manipulating the genome in a spatially or temporally 
controlled manner. For example, a knock-out of a given gene results in the absence of 
its expression in all cells of the animal and throughout pre- and post-natal 
development, thus precluding the analysis of the gene’s function in a specific cell type 
or at a given time.  
 
These conventional genome modifications can be combined with site-specific 
recombination systems to generate tissue-specific, time-specific or inducible genetic 
alterations. 
 
1.5.1. Conditional mutagenesis: the Cre-loxP system 
The Cre/loxP recombination system has been successfully used as a tool for genome 
engineering (Sauer, 1998). Cre is a 38 kDA recombinase protein from bacteriophage 
P1 which catalizes site specific recombination between two loxP sites (locus of 
crossing over). A loxP site consists of two 13 basepair inverted repeats separated by 
an 8 basepair asymmetric spacer region (Fig. 4).    47
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Application of Cre/loxP approach for cell type specific expression. 
Expression of Y gene in the double mutant is initiated by cell specific Cre-mediated 
recombination between two loxP sites and consequent excision of a STOP cassette. 
Sequence of a loxP site is depicted in callout balloon. 
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Depending on the relative orientation of the loxP sites, Cre-mediated recombination 
can result in DNA excision or inversion. Recombination between two loxP sites 
positioned in the same orientation excises the intervening DNA whereas 
recombination between loxP sites positioned in inverted orientations inverts the 
intervening DNA sequences. If the two loxP sites are located in different 
chromosomes, the product is a interchromosomal translocation (reviewed in (Sauer, 
1993)). 
 
1.5.1.1. Conditional gene activation 
The exact excision of DNA can be used to eliminate a gene (conditional gene 
deletion) or alternatively to activate a transgene (conditional gene activation) by 
excising an intervening stop sequence between the promoter and the coding region of 
the transgene (Fig. 4).  
 
For this purpose, two mouse strains are required. One is a mouse line expressing Cre 
in a lineage-specific manner. Cre can either be introduced into the genome by 
conventional transgenesis or can be ‘knocked in’ into a defined locus to give the 
required expression. 
 
The second mouse strain has a transgene incorporated whose 5' regulatory elements 
are separated from the coding region with a loxP-flanked (or floxed) stop sequence. 
The recombination, i.e. excision of the stop signal, occurs only in those cells 
expressing Cre depending on the specificity of the Cre construct. Therefore, the 
transgene can be transcribed in this special cell type whereas it remains inactive in all 
other Cre non-expressing cells.   49
This second strain can be used for gene activation in a number of different tissues or 
at different developmental times, by simply mating with a Cre strain that displays the 
desired tissue or temporal specificity of expression. 
 
The Cre/loxP system can also be used to generate inducible gene (in)activation. For 
this purpose, the expression of Cre is controlled by a inducible promoter, for example, 
the promoter of the Mx1 gene. This gene is not expressed in healthy animals, but it is 
transiently activated by interferon (IFN)α or IFNβ or poly-IC. The progeny of mice 
carrying the Mx1-cre transgene and mice carrying a floxed allele can be treated with 
IFN or poly-IC to inactivate the floxed target gene (Kuhn et al., 1995; Seibler et al., 
2003). 
 
1.5.1.2. Strain validation 
The availability of Cre mouse strains in which Cre activity is tightly controlled in 
space and time is critical to the success of conditional mutagenesis. Indeed, leaky 
expression of Cre from a cell-type specific or inducible promoter can occur, resulting 
in recombination events in unwanted cell types (Gustafsson et al., 2001; de Boer et 
al., 2003) or at the wrong time (Kuhn et al., 1995). The expression of Cre can also be 
mosaic, in which case the excision will only occur in a subset of cells of a given tissue 
(Campsall et al., 2002).  
 
Therefore it is essential to evaluate the pattern of Cre expression at the cellular level. 
RNA or DNA methods have the limitation of giving an estimate of the overall 
recombination rate of total populations of cells rather than of individual cells. On the 
other hand, reporter mouse strains allow monitoring of Cre-mediated recombination at   50
the single-cell level. In these lines, expression of a cellular marker (for example 
yellow fluorescence protein (YFP)) can be checked by flow cytometry. 
 
One commonly used reporter mouse strain has the YFP gene targeted to the 
ubiquitously expressed Rosa26 gene locus (Srinivas et al., 2001). As expression from 
the R26 locus is ubiquitous, any leaky expression of Cre can be readily detected. 
Another advantage of this reporter over similar reporters, such as lacZ, is that 
visualization of YFP in living tissue does not require a substrate.  
 
1.5.2. Cell ablation by Diphtheria toxin gene expression 
Diphtheria toxin (DT) is secreted by Corynebacterium diphtheriae, the causative 
agent of diphtheria. Once internalized into a mammalian cell, diphtheria toxin blocks 
protein synthesis and causes rapid cell death. The toxin polypeptide is composed of 
two subunits: DTA and DTB. The DTB subunit binds to the receptor, a cell surface 
expressed heparin-binding epidermal growth factor (HB-EGF), facilitating the 
translocation of DTA into the cell. Once inside the cell, DTA is extremely toxic. Its 
enzymatic activity (ADP rybosylation of elongation factor 2) leads to the inhibition of 
protein synthesis and concomitant host cell death (Collier, 2001; Naglich et al., 1992).  
 
Intracellular production of diphtheria toxin has been used to kill cells in a variety of 
systems. Killing of cells within a selected lineage can be achieved by transgenic mice 
that express the diphtheria toxin under the control of cell-specific regulatory elements 
or have diphtheria toxin ‘knocked-in’ into specific locus (Palmiter et al., 1987; 
Breitman et al., 1987; Kaplan et al., 2005). Alternatively, expression of diphtheria 
toxin in a cell type specific manner can be driven by Cre-expression by using the   51
Cre/loxP system described above (Matsumura et al., 2004; Brockschnieder et al., 
2004). In this case, a floxed stop cassette is inserted between the promoter and the 
DTA gene, thereby preventing expression of the toxin independently of Cre. 
 
1.5.2.1. DTA mode of action 
DT induces apoptosis by inhibition of protein synthesis and activating components of 
the death receptor pathway, thus without inducing inflammation or other side effects 
(Thorburn et al., 2003; Bennett et al., 2005; Miyake et al., 2007). 
 
Studies performed in the related DT receptor (DTR)/DT based system, have shown 
that DTA-mediated depletion occurs within 24 hours after injection of DT (Bennett et 
al., 2005).  
 
Even if released from the cytoplasm of apoptotic cells, the DTA fragment is unable to 
enter neighbour cells in the absence of the DTB fragment, thus preventing non-
specific cell death (Palmiter et al., 1987). In addition, sensitivity of mammalian cells 
to diphtheria toxin varies with the receptor. Rat and mouse cells are resistant because 
their receptor has very low affinity for the toxin (Cha et al., 1999).   52
1.6. Aim of this work 
The aim of this work was to understand the contribution of HIV driven CD4
+ T cell 
depletion for AIDS pathogenesis. Due to the complexity of phenomena triggered by 
the virus during infection, it is very difficult to disentangle the relationship between 
cause and effect of CD4
+ T cell depletion and immune activation. For this reason, we 
have chosen a reductionist approach to deplete the same cells that HIV targets, 
namely activated CD4
+ T cells, in a virus-free system. We have chosen the mouse 
model due to the availability of genetically altered strains that allow us to specifically 
deplete the desired cell types. With this model, we intended to dissociate CD4
+ T cell 
depletion from any other effects the virus might have in the development of disease 
and observe whether CD4
+ T cell depletion of activated cells alone is sufficient to 
generate all or some of the homeostatic disturbances observed in HIV infection.   53
2. Materials & Methods 
 
2.1. Animals 
Inbred C57BL/6 (B6) and CD45.1-congenic B6 mice (B6.SJL-Ptprc
a Pep3
b/BoyJ) 
were originally obtained from the Jackson Laboratory (Bar Harbor, Maine, USA) and 
were subsequently maintained at NIMR. B6-backcrossed Rag1-deficient mice 
(B6.129S7-Rag1
tm1Mom/J or Rag1
-/-) (Mombaerts et al., 1992), Rag2-deficient mice  
(B6.129-Rag2
tm1Shi or Rag2
-/-) (Shinkai et al., 1992), MHCII-deficient mice 
(B6.129S2-H2
dlAb1-Ea/J or MHCII
-/-) (Madsen et al., 1999) and T cell receptor α 
(TCRα)-deficient mice (B6.129-Tcra
tm1Phi or Tcra
-/-) (Philpott et al., 1992) have been 
previously described  and have also been maintained at NIMR.  
 
Mice with an activatable gene encoding YFP targeted into the ubiquitously expressed 
Gt(ROSA)26Sor (R26) locus have been described (Srinivas et al., 2001) and were 
backcrossed onto the B6 genetic background for at least 10 generations. 
 
Mice with an activatable gene encoding diphtheria toxin fragment A (DTA) targeted 
into the R26  locus were kindly provided by Drs Adam Williams and Dimitris 
Kioussis, Division of Molecular Immunology, NIMR. They were generated by gene-
targeting in embryonic stem cells which were subsequently injected into B6 
blastocysts. Germ-line transmitting R26
Dta/+  mice were backcrossed onto the B6 
genetic background for at least 6 generations.  
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Mice with a targeted insertion of Cre recombinase into the Tnfrsf4 locus have been 
kindly provided by Dr Nigel Killeen, Department of Microbiology and Immunology, 
University of California, USA, and were backcrossed onto the B6 genetic background 
for at least 6 generations.  
 
To obtain Tnfrsf4
Cre/+ R26
Dta/+ progeny, homozygous Tnfrsf4
Cre/Cre mice were mated 
with heterozygous R26
Dta/+  mice. In all experiments Tnfrsf4
Cre/+  R26
+/+  littermates 
were included as controls for Tnfrsf4
Cre/+ R26
Dta/+ mice to control for any potential 
effects of CD134 hemizygosity.  
 
Mice with intestinal epithelial cell-specific deletion of Ikbkg (encoding for IKKγ, also 
called NEMO) were obtained by crossing mice with a floxed Ikbkg allele (Ikbkg
fl/-)
 
with mice expressing Cre under the intestinal epithelial-specific Villin promoter (Vil-
Cre) and have been previously described (Nenci et al., 2007). Ikbkg
fl/- Vil-Cre and 
control Ikbkg
fl/- mice were bred and maintained at the Institute for Genetics, Cologne, 
Germany. Spleens and lymph nodes from Ikbkg
fl/- Vil-Cre and control Ikbkg
fl/- mice 
were harvested at Cologne and shipped to NIMR, where they were analysed the 
following day.  
 
All animal experiments were conducted according to local government regulations 
and institutional guidelines.   55
 
2.2. Flow cytometry 
2.2.1. Cell and tissue preparation 
Single cell suspensions were prepared from thymus, spleen or lymph nodes of donor 
mice by mechanical disruption through a 70 µm cell strainer (Falcon, Becton 
Dickinson Labware). All cell suspensions were prepared and kept in Air-Buffered 
(AB) Iscove’s Modified Dulbecco’s Medium (IMDM) containing 25 mM HEPES 
buffer and L-glutamine and supplemented with 0.21% NaCl, 60 µg/ml penicillin, 100 
µg/ml streptomycin (Invitrogen, Life technologies), and 2% heat inactivated foetal 
calf serum (FCS) from BioSera.  
 
Spleen cell suspensions were treated with ACK lysis buffer (0.15 M NH4Cl, 1 mM 
KHCO3, 0.1 mM EDTA, pH 7.2-7.4) for erythrocyte lysis. Bone marrow cell 
suspensions were prepared by flushing the bone cavities of femurs and tibiae from 
donor mice with AB IMDM and red blood cells were lysed with ACK lysis buffer. 
Peritoneal cells were obtained by carefully injecting 5 ml of AB IMDM intra-
peritoneally (i.p.) in euthanized mice, followed by gentle abdominal massage and 
subsequent aspiration of medium-containing cells.  
 
Cell numbers were determined by an automated cell counter (Casy1, Schaerfe 
Systems). Lymph node cellularity was calculated as the sum of the cellular contents of 
inguinal, axillary, brachial, superficial cervical and mesenteric lymph nodes. Total 
numbers of each cell type in each organ were calculated from the frequency of each   56
cell type determined by flow cytometry, and the total number of cells recovered from 
each organ. 
2.2.2. Cell surface marker staining 
Cell surface expression of lymphocyte antigens was measured by monoclonal 
antibody (mAb) staining of freshly isolated cells, followed by Fluorescence Activated 
Cell Sorter (FACS) analysis. Cell concentrations were adjusted to 10
7cells/ml for 
analysis. Cells were incubated with anti-FcR monoclonal antibody (2.4G2) to block 
non-specific binding through Fc receptors, and stained with directly-conjugated 
antibodies to surface markers or biotin-conjugated mAbs for 20-30 minutes, followed 
by PE-TexasRed-, APC-Cy7- or PerCP-streptavidin staining. All stainings were 
performed at 4
oC and cells were washed with FACS buffer (phosphate-buffered saline 
(PBS), 2% FCS, 0.1% azide). Antibodies used were obtained from eBiosciences, 
CALTAG/Invitrogen, BD Biosciences or prepared at NIMR and are summarized in 
Table 1.  
 
Shedding of the adhesion molecule L-selectin (CD62L) was prevented by preparing 
cell suspensions in medium containing 50 µM of the inhibitor TAPI-2 (Peptides 
international, Inc) in an adaptation of a previously described procedure (Jabbari and 
Harty, 2006). 
 
Up to 4-colour samples were acquired on an analytical flow cytometer (FACSCalibur, 
BD Biosciences) and analyzed with FlowJo v8.7 software (Tree Star Inc). Up to 8-
colour cytometry was performed on a CyAn flow cytometer (Dako) and analyzed with 
Summit v4.3 analysis software (Dako).   57
 Table  1: Specificity and clone name of anti-mouse Abs used for extra-cellular 
staining. Alternative names are show in parenthesis. 
 
Specificity Clone  name  Company 
Fcγ III/II R  2.4G2  Made at NIMR 
CD4 (L3T4)  RM4-5  eBiosciences / Caltag 
CD8a (Ly-2)  53-6.7  eBiosciences /BD Biosciences 
CD11b (Mac1α; integrin αM 
chain) 
M1/70 eBiosciences 
CD11c  (integrin αX chain)  N418  eBiosciences 
CD19 MB19-1  eBiosciences 
CD25 (IL-2 receptor α chain  PC61.5  eBiosciences 
CD38 90  eBiosciences 
CD43 (Ly-48; leukosialin)  1B11  BD Biosciences  
CD44 (Pgp-1; H-CAM; Ly-24)  IM7  eBiosciences 
CD45.1 (Ly-5.1)  A20  eBiosciences 
CD45.2 (Ly-5.2)  104  eBiosciences 
CD45R (B220)  RA3-6B2  eBiosciences 
CD45RB C363.16A  eBiosciences 
CD49b (integrin α2 chain)  HMα2  BD Biosciences  
CD62L (L-selectin; LECAM-
1; Ly-22) 
MEL-14 eBiosciences 
CD70 FR70  eBiosciences 
CD103 (integrin αIEL chain)  2E7  eBiosciences 
CD127 (IL-7receptor α chain)  A7R34  eBiosciences 
CD134 (Ox40)  OX-86  eBiosciences 
TCR β H57-597  eBiosciences 
IgM  DS-1  BD Biosciences  
IgD 11-26c  eBiosciences 
MHCII (I-A
b) M5/114.15.2  eBiosciences 
Ter119/Erythroid cells (Ly-76)  TER-119  eBiosciences 
Gr1 (Ly-6G)  RB6-8C5  eBiosciences 
F4/80 BM8  eBiosciences 
GL7 (Ly-77)  GL-7  BD Biosciences  
Glyco-Gag 34  Made  at  NIMR 
mIgG2b-FITC  R12-3  BD Biosciences  
2
nd layers    
streptavidin-PETxR   Caltag   
streptavidin-APCCy7    BD Biosciences  
streptavidin-PerCp   BD  Biosciences     58
2.2.3. Intracellular cytokine staining 
For intracellular cytokine staining, cytokine production was induced by stimulating 
cells for 4 hours with phorbol 12, 13-dibutyrate (PDBu) and ionomycin (both at 0.5 
µg/ml, from Sigma chemical Co) at 37°C, together with surface staining antibodies. 
One hour later, an inhibitor of intracellular transport, monensin (at 1µg/ml), was 
added to block secretion of cytokines. Three hours later, cells were washed and 
resuspended in fixation buffer (eBioscience) for 20 minutes at room temperature (RT) 
and then washed and incubated in permeabilization buffer (eBioscience) with 
antibodies for cytokine staining for one hour at RT. Antibodies used for cytokine 
intracellular staining are summarized in Table 2. 
 
Table 2: Specificity and clone name of anti-mouse Abs used for cytokine intra-
cellular staining. 
Cytokines  Clone name  Company 
IFN-γ XMG1.2 eBiosciences 
IL-10 JES5-16E3  eBiosciences 
IL-2 JES6-5H4  eBiosciences 
TNF-α MP6-XT22  eBiosciences 
IL-4 11B11 eBiosciences 
IL-17A TC11-18H10.1  eBiosciences 
 
 
2.2.4. FoxP3 intranuclear staining 
Intranuclear staining for Foxp3 was done with a Foxp3 staining kit purchased from 
eBioscience following manufacturer’s instructions. Briefly, 10
6 cells were first stained 
for surface molecules. Cells were then washed and incubated for 1 hour at 4°C with 
fixation/permeabilization buffer and then washed 3 times with permeabilization buffer   59
followed by staining with anti-Foxp3 antibody (Clone FJK-16s) at 4°C for at least 30 
minutes. 
 
2.2.5. Analysis of cell turnover by BrdU 
BrdU is a thymidine analogue that incorporates into dividing cells during DNA 
synthesis (Gratzner, 1982). Mice were given BrdU (Sigma chemical Co) -containing 
water (0.8 mg/ml) for 7 days following a single i.p. administration of 0.8 mg of BrdU. 
BrdU-containing water preparations were made fresh or kept frozen, changed daily 
and kept protected from light. Single cell suspensions of the spleen and lymph nodes 
were labelled with cell-surface antibodies, as usual, washed and fixed for one hour to 
overnight with fixation buffer (eBioscience) and washed. Afterwards they were 
incubated with 0.1% NP40 (Sigma chemical Co) in PBS-azide-free for 3 minutes on 
ice, washed twice and stained with 20-40 µl of  FITC-conjugated anti-BrdU (clone 
B44) with DNase (FastImmune Anti-BrdU FITC with DNase) in the dark for one 
hour. 
 
2.2.6. Analysis of cell turnover by Ki67 
Ki67 is a nuclear cell proliferation-associated antigen expressed in all active stages of 
the cell cycle (Kubbutat et al., 1994) that was detected by intranuclear staining. The 
fixation protocol and reagents used were similar to the ones used for FoxP3 staining 
except that 20 µl of PE mouse anti-human Ki-67 or matched isotype control were 
used (clone B56 and clone MOPC-2, respectively, both provided in PE mouse anti-
human Ki-67 set from BD Pharmingen). 
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2.2.7. Analysis of apoptosis by Annexin V staining 
Apoptosis was assessed by Annexin V staining. In the early stages of apoptosis, cells 
expose phospholipid phosphatidylserine to the external cellular environment which is 
bound by Annexin V. Cells that are undergoing apoptosis can therefore be detected by 
flow cytometry using Annexin V conjugated to a fluorochrome (Vermes et al., 1995). 
 
Apoptotic cells were stained using an AnnexinV-PE Apoptosis detection Kit (BD 
Biosciences) according to the manufacturer’s instructions. Briefly, cells were stained 
with 5 µl of Annexin V-PE and 5 µl of 7-AAD in binding buffer provided for 15 
minutes at RT in the dark and analysed within one hour. 
 
2.2.8. Cell purification and sorting 
Target cells were enriched in lymph node and spleen suspensions using 
immunomagnetic positive or negative selection (EasySep beads, StemCell 
Technologies) according to the manufacturer’s instructions. For example, for in vitro 
T cell activation experiments, negative selection was performed by first staining the 
cells with CD8α- and B220-PE conjugated antibodies. Then, PE selection cocktail 
was added and single cell suspension incubated at RT for 20 minutes. Magnetic beads 
were added and incubated for a further 15 minutes at RT. The tube containing the 
cells was then placed on a magnet (EasySep Magnet) for 10 minutes and supernatant 
was poured off to a new tube which was loaded on the magnet. After repeating this 
procedure two times, negatively-selected cells were collected, centrifuged and 
counted.    61
For in vivo regulatory CD4
+ T cell transfers, positive selection was done following the 
same purification procedure as described above, with the exception that cells were 
initially stained with CD25 PE-conjugated antibody and in the last step, tube with 
cells was placed on the magnet for 5 minutes, and supernatant was poured off. After 
two washes, positively-selected cells were collected by removing the tube from the 
magnet.  
 
Enriched cell suspensions were counted and when necessary stained with antibodies 
to surface markers and then further purified by cell sorting, performed on MoFlo cell 
sorters (Dako) by the NIMR Cell Sorting facility. Typical cell purity following cell 
sorting was higher than 98%. 
 
2.3. In vitro T cell activation 
Culture medium used for in vitro cultures and cell lines was IMDM supplemented 
with 5% heat inactivated FCS (BioSera) and 2 mM L-glutamine, 100 U/ml penicillin, 
100 µg/ml streptomycin and 10
-5 M mercaptoethanol (all Sigma Chemicals Co). 
 
For YFP in vitro kinetics, single cell suspensions were prepared from the spleen and 
lymph nodes of Tnfrsf4
Cre/+ R26
Yfp/+ mice. CD4
+ T cells were purified by using CD8/ 
B220 negative selection by Easysep beads and subsequently sorted as CD4
+YFP
-. 
Depending on the experiment, 0.25 × 10
6, 0.5 × 10
6 or 4.5 × 10
6 sorted T cells per 
well were stimulated in 96 well-plates with CD3/CD28 coated beads (Dynal Mouse 
CD3/CD28 T Cell Expander, Invitrogen Dynal AS), at 1:1 ratio for the indicated 
length of time in IL-2 (10 ng/ml) containing IMDM medium. 
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For in vitro apoptosis analysis, single cell suspensions were prepared from the spleen 
and lymph nodes of Tnfrsf4
Cre/+  R26
Dta/+  mice. CD4
+ T cells were purified as 
described for YFP analysis and sorted as CD4
+CD25
-CD45RB
high cells. Purity after 
sort was 98% in one experiment and 99% in another experiment. Depending on the 
experiment, 0.75-1 × 10
6 sorted naïve T cells per well were stimulated as described 
for YFP analysis. 
 
2.4. Histology 
Organs were collected in formalin immediately after donor death and sent for 
histological analysis (Dr Mark Stidworthy at IZVG Pathology, Leeds, UK). For the 
analysis of growth retarded and normal Tnfrsf4
Cre/+ R26
Dta/+ mice the following organs 
were collected: skin, kidney, lung, brain, salivary glands, stomach, liver, gall bladder, 
pancreas, small and large intestines, spleen and lymph nodes. Histological sections 
were stained with haematoxylin and eosin (H&E) unless otherwise stated. 
 
2.5. Serum preparation 
Serum was prepared by leaving non-heparinised blood to clot at room temperature for 
2 hours or at 4°C overnight. Clot was then detached from the sides of tubes which 
were then centrifuged at 3,000 rpm for 5 minutes. Clear sera were transferred to new 
tubes which were centrifuged at 12,000 rpm for 5 minutes. Clear sera were transferred 
to new tubes. For luminex assay and detection of serum immunoglobulins, sera were 
stored at -20°C. For neutralizing antibody (nAb) assays, sera were first heat 
inactivated at 56°C for 10 to 15 minutes and then stored at -20°C.    63
2.6. Analysis of serum cytokines by luminex assay 
Simultaneous measurement of serum levels of mouse fibroblast growth factor (FGF) 
basic, vascular endothelial growth factor (VEGF), granulocyte-macrophage colony-
stimulating factor (GM-CSF), interferon-gamma (IFN-γ), tumour necrosis factor 
(TNFα), IL (interleukin) -1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12p40⁄p70, IL-
13, IL-17, IP-10 (or chemokine (C-X-C motif) ligand 10 (CXCL10)), KC (CXCL1), 
monocyte chemotactic protein-1 (MCP-1 or Chemokine (C-C motif) ligand 2 
(CCL2)), macrophage inflammatory protein-1 α (MIP-1 α or CCL3) and monokine 
induced by IFNγ (MIG or CXCL9) was performed by using a multiplex cytokine bead 
array (20-plex ab bead kit, BioSource), using the Luminex 100 System (Luminex). A 
second experiment was done using a multiplex cytokine bead array (BioRad) allowing 
the detection of seven additional factors: IL-3, IL-9, IL12p70, Eotaxin (CCL11), G-
CSF, MIP-1β (CCL4), regulated upon activation, normal T cell expressed and 
secreted (RANTES or CCL5). 
Serum samples were diluted two fold in PBS, and 50 µl transferred to 96 well plates 
pre-wet in Bio-Plex assay buffer and containing 50 µl of multiplex beads. Samples 
were incubated for 60 minutes at room temperature in a plate shaker (300 rpm) 
followed by 3 washes with Bio-Plex wash buffer and the addition of 50 µl of biotin-
labelled detection antibody. Following 30 minutes incubation at room temperature in 
plate shaker and 3 washes, 25 µl of Streptavidin-PE were added and a further 
incubation step for 10 minutes at room temperature was performed. Following 3 
washes, samples were ressuspended in 150 µl of Bio-Plex assay buffer and analysed 
on the luminex 100 System.   64
 
2.7. Bone marrow chimeras  
Whole
 bone marrow cells (after red blood cell lysis) were injected intravenously (i.v.) 
into non-irradiated Rag-deficient mice via the tail vein in 0.1-0.2 ml of AB IMDM. 
Recipient mice were periodically bled via the tail vein to analyse peripheral blood for 
reconstitution and were killed and analysed twelve to fourteen weeks after transfer. 
Donor- and recipient-derived cells were distinguished by cell surface expression of 
CD45.1 or CD45.2 allotypes. In mixed bone marrow chimeras experiments, mixed 
populations were injected at a 1:1 ratio.  
 
2.8. Adoptive transfer of cells 
For transfers into TCRα
-/- recipients, titrating amounts of CD4
+ T cells (purified by 
positive selection) were injected i.v. via the tail vein in 0.1 ml of AB IMDM. Total 
amount of CD4
+ T was considered to be ~6x10
7/mouse (Bourgeois et al., 2005) and 
percentage of ‘take’ in cell transfer ~20%. Accordingly 3x10
7, 3x10
6, 3x10
5 and 3x10
4 
cells were transferred to represent 10%, 1%, 0.1% and 0.01% of total CD4
+ T cells of 
B6 mice.  
 
For regulatory T cell transfer experiments, 1-3x10
6 sorted CD4
+CD25
bright cells (Fig. 
5) from spleen and lymph nodes of WT mice were injected i.v. via the tail vein in 
Tnfrsf4
Cre/+ R26
Dta/+ and control mice and periodically tail bled. Mice were killed and 
analysed 7-10 weeks post transfer.   65
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Sort profile of CD4
+CD25
bright cells. Cell suspension from spleen and 
lymph nodes from 30 B6.CD45.1 mice were enriched with immunomagnetic positive 
selection for CD25 and further purified by cell sorting. The flow cytometry plot 
shows the positioning of the gate used to sort CD4
+CD25
bright cells. The plot is of one 
out of 3 independent experiments. In all 3 experiments, purity was ≥98%. 
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2.9. Experimental infections in mice 
2.9.1. Friend virus infection   
The Friend virus (FV) used in this study is a retroviral complex of a replication-
competent B-tropic helper murine leukaemia virus (F-MuLV-B) and a replication-
defective polycythemia-inducing spleen focus-forming virus (SFFVp). The FV stock 
(kindly provided by Dr. Kim Hasenkrug, Laboratory of Persistent Viral Diseases, 
Rocky Mountain Laboratories, NIAID, NIH, Hamilton, MT, USA) was free of lactate 
dehydrogenase-elevating virus (LDV) and was obtained as previously described 
(Robertson et al., 2008). FV was propagated in vivo and prepared as 10% w/v 
homogenate from the spleen of 12-day infected BALB/c mice. Mice received an 
inoculum of FV complex containing between 1,000-2,000 spleen focus-forming units 
(SFFU) injected via the tail vein in 0.1 ml of PBS. 
 
2.9.1.1. Friend virus detection by FACS   
Cell-associated virus in infected mice was estimated by flow cytometric detection of 
infected cells using surface staining for the glycosylated product of the viral gag gene 
(glyco-Gag), using the matrix (MA)-specific monoclonal antibody 34 (mouse IgG2b), 
followed by an antimouse IgG2b-FITC secondary reagent (Table 1). 
 
2.9.1.2. Friend virus nAb titre assay   
FV-neutralizing antibodies in the sera of infected mice were measured using a 
modification of a previously described viral titre assay (Bock et al., 2000). Mus dunni   67
cells (Lander and Chattopadhyay, 1984) were transduced with the XG7 replication-
defective retroviral vector, expressing green fluorescent protein (GFP) from a human 
cytomegalovirus (hCMV) promoter and a neomycin-resistance gene under the control 
of the LTR (Bock et al., 2000). Mus dunni and Mus dunni-XG7 cells were both kindly 
provided by Dr J. Stoye, Division of Virology, NIMR. Maintenance of GFP 
expression was ensured by constant selection with 1 mg/ml G418. Mus dunni-XG7 
cells were then infected with F-MuLV-B and supernatant, which contained the 
pseudotyped XG7 vector, was harvested. Serial dilutions of sera from infected mice 
were mixed with ~1,500 infectious units (iu)/ml pseudotyped XG7 vector and allowed 
to incubate for 30 minutes at 37°C in IMDM cell culture medium containing 5% FCS. 
Mixtures were then added to untransduced Mus dunni cells and incubated for 3 days. 
The percentage of GFP
+ Mus dunni cells at the end of the incubation period was 
assessed by flow cytometry and the dilution of serum which resulted in 75% 
neutralization (i.e. 75% reduction in the percentage of GFP
+ Mus dunni cells) was 
taken as the neutralizing titre. 
 
2.9.2. Influenza virus infection 
The A/PR/8/34 (PR8) strain of influenza A virus (IAV) (kindly provided by Ms Rose 
Gonsalves, Division of Virology, NIMR) was an allantoic fluid preparation from 
PR8-infected embryonated eggs. Non-anaesthetized mice were infected with 250 
hemagglutinin units (HAU) of PR8 by instillation onto their nasal cavities. After 6, 12 
and 18 days, non-heparinised blood was collected by tail bleeding.  
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2.9.2.1. Influenza nAb titre assay 
Serum titres of PR8-neutralizing antibodies were measured using a modified Madin 
Darby canine kidney (MDCK)-based assay. Serial dilutions of the sera were added to 
monolayers of MDCK cells in 96-well COSTAR cell culture plates (Corning, Inc), 
which were subsequently infected with a tissue culture infective dose (TCID95) of 
PR8. MDCK cell viability was measured with an Alamar blue (Biosource) based 
assay 3 days after infection. Cultures were washed and pulsed with Alamar blue for 1-
2 hours and fluorescence was measured with a fluorescence plate reader (Safire, 
Tecan). The dilution of serum which resulted in 50% neutralization of MDCK death 
was taken as the neutralizing titre. 
 
2.9.3. Pneumocystis murina infection 
Pneumocystis murina (P. murina) was obtained from ATCC/LGC Promochem (stock 
PRA-111) as lung tissue homogenate from P. murina infected rats. Non-anaesthetized 
mice were administered P. murina by instillation onto their nasal cavities. Mice were 
killed 17 weeks later, and left lower lung lobe was removed and frozen and 
subsequently used to extract genomic DNA. The remaining lung tissue was gently 
inflated via the tracheae with formalin and sent for histological analysis. Histological 
sections were examined for general architecture (haematoxylin and eosin (H&E) 
stain) and Pneumocystis organisms (Gomori’s silver stain). 
 
2.9.3.1. Detection of Pneumocystis in lungs by PCR 
Lungs were incubated overnight with 0.5 ml of lysis buffer (100 mM Tris-HCl 
(pH7.5), 5 mM EDTA, 200 mM NaCl, 0.2% SDS) and 200 µg/ml proteinase K   69
(Roche diagnostics GmbH). The extracts were treated with buffered phenol and DNA 
was precipitated with ethanol and dissolved in water. To detect P. murina in the lung, 
DNA samples were subjected to nested PCR using specific primers (MGW biotech 
AG) for the mitochondrial large-subunit ribosomal RNA (rRNA) of P. murina. PCR 
reactions contained ~50 ng of the genomic DNA, 2 mM MgCl2 (Abgene Ltd), 0.2 mM 
dNTP (G.E. Healthcare), 0.4 pmol/µl sense and antisense primer, and 0.1 U Taq DNA 
polymerase (Abgene Ltd) in the supplier’s buffer in a volume of 20 µl, and were 
amplified in an Eppendorf mastercycler termocycler. PCR amplifications were carried 
out with a 2.5 minutes denaturation step at 94˚C and then 30 cycles of denaturation at 
94˚C for 30 seconds, annealing at 55˚C for 30 seconds and extension at 72˚C for 30 
seconds, followed by a final 5 minutes extension at 72˚C. Nested PCR amplifications 
were performed using 1 µl of this PCR product following the same protocol except 
for the annealing temperature which was 50˚C. The outer primers were pAZ102-H 
(5’-GTG TAC GTT GCA AAG TAC TC-3’) and pAZ102-E (5’-GAT GGC TGT 
TTC CAA GCC CA-3’). The internal primers were pAZ102-X (5’-GTG AAA TAC 
AAA TCG GAC TA-3’) and pAZ102-Z (5’-CCC ACT TCT T(A/G)A CTG TC-3’) as 
described elsewhere (Hori et al., 2002). The expected product size is 346 bp for the 
first PCR and 263 for the nested PCR. As a control, PCR amplifications of mouse 
Rag-1 gene were also performed. The primers were 5’-CTG TAG GAT CTG CAT 
TCT CAG ATG TC-3’ and 5’-CAG CCT TCA CAT CTC CAC CTT CTT C-3’, and 
the PCR condition were the same as described above. PCR products were separated 
on a 2% agarose gel containing ethidium bromide.  
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2.10. Analysis of serum immunoglobulins by ELISA 
Serum immunoglobulin (Ig) levels were determined by a standard enzyme-linked-
immunosorbent-assay (ELISA) technique. 50 µl of test supernatants were added to 
96-well polyvinyl flexiplates (Thermo Electron Corporation) coated overnight with 50 
µl of unlabeled goat anti-mouse Ig (H+L) (Southern Biotech) at 5µg/ml in coating 
buffer (0.2 M borate buffer, pH 8.5) and blocked with PBS supplemented with 10% 
FCS for at least 1 hour at RT. Following 3 washes, 50 µl of secondary antibody (IgG-
Alkaline phosphatase (AP) or IgM-AP, 1:1,000) (Southern Biotech) were added and 
incubated for 1 hour at RT. Wells were extensively washed and 200 µl of alkaline 
phosphate yellow liquid substrate (Sigma Chemicals Co) was added. Absorbance was 
read at 405 nm when yellow reaction products were formed. All washes were done 
with PBS supplemented with 0.05% tween20 (Sigma Chemicals Co). 
 
2.11. Statistical analysis 
Statistics were generated by Student’s t-test performed using SigmaPlot v10 software 
(Systat Software Inc). p values <0.05 were considered to be statistically significant.   71
3. Results 
 
 
 
 
 
3.1. Specific targeting of memory and regulatory CD4
+ T cells 
by Tnfrsf4-driven Cre expression 
Immunodeficiency viruses are highly selective for activated/memory CD4
+ T cells 
due to restricted expression of their receptors/co-receptors. One of the most specific 
markers of activation in CD4
+ T cells is CD134, the cellular receptor for FIV. We 
generated a mouse model in which activated CD4
+ T cells, i.e. CD134
+CD4
+ T cells 
are targeted.  
 
Specificity of CD134 (encoded by Tnfrsf4 gene) expression was evaluated using a 
reporter mouse strain. This strain was obtained by crossing the Tnfrsf4
Cre/Cre knock-in 
strain in which Cre is knocked-in into the CD134 locus, with the R26
Yfp/Yfp strain 
(Srinivas et al., 2001), in which expression of yellow fluorescent protein (YFP) under 
the ubiquitously expressed R26 promoter is prevented by a loxP flanked (floxed) stop 
cassette. We named this strain Tnfrsf4
Cre/+  R26
Yfp/+. Cre mediates excision of the 
floxed stop cassette in the R26 locus activating the YFP gene. Consequently, in these 
animals, all cells that are expressing or have expressed CD134-driven Cre (as well as 
their daughter cells), will also express YFP. 
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We examined the frequency of YFP-expressing cells in Tnfrsf4
Cre/+ R26
Yfp/+ mice by 
flow cytometry. The fluorescence intensity of YFP in these mice is very bright 
allowing an easy characterization of YFP-expressing cells (Fig. 6). 
 
In the thymus, where only ~ 1% of all cells expressed YFP (Fig 6), the majority of 
these were CD4 single positive (SP) thymocytes and ~ 30% were double positive 
(DP) thymocytes (Fig. 7-B). YFP was hardly detected on CD8 SP cells (Fig. 7-B). 
Mature CD4
+ T cells can be subdivided into naïve, memory, and regulatory cells 
according to the expression of CD25 and CD44 markers. Naïve cells are CD25
-
CD44
low, memory cells are CD25
-CD44
high and regulatory cells are CD25
+CD44
int 
(Fig. 7-C). This has been the classification used throughout this work. While only 
approximately 14% of memory CD4
+ T cells expressed YFP, more than half of 
regulatory CD4
+  T cells (56%) expressed YFP (Fig. 7-D). Although it cannot be 
excluded that some of these cells could be re-circulating, this is consistent with the 
observation that the regulatory CD4
+ T cell subset is already activated in the thymus 
(Takeda et al., 2004). 
 
In the spleen, the number of YFP
+ cells increased with age until 8 weeks, possibly 
reflecting an age-related increase in antigen-experienced cells in this organ. In adult 
mice, lymph nodes contained approximately 6% of cells expressing YFP, while in the 
spleen these cells constituted around 4% of the total cells (Fig. 8-A).    73
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Intensity of YFP expression in Tnfrsf4
Cre/+ R26
Yfp/+ mice. Flow cytometric 
analysis of YFP expression in thymus (THY), spleen (SP) and lymph nodes (LN) of 
Tnfrsf4
Cre/+ R26
Yfp/+ mice at 8 weeks of age. Numbers within dot plots indicate the 
percentage of YFP
+ cells. 
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Figure 7. YFP expression in thymic subsets in Tnfrsf4
Cre/+ R26
Yfp/+ mice. (A) Flow 
cytometric example of subdivision of thymocytes in CD4
+CD8
+ (DP), CD4
+CD8
- 
(CD4 SP) and CD4
-CD8
+ (CD8 SP) subsets. (B) Frequency of DP, CD4 SP and CD8 
SP in gated YFP
+ thymocytes in Tnfrsf4
Cre/+  R26
Yfp/+  mice.  (C) Flow cytometric 
example of subdivision of CD4 SP cells into naïve (N, CD44
lowCD25
-), memory (M, 
CD44
highCD25) and regulatory (R, CD25
+) subsets. (D) Percentage of YFP
+ cells in 
the indicated subsets. Mean values (±SEM) of 9 mice are shown. 
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Figure 8. YFP expression in peripheral lymphoid organs of Tnfrsf4
Cre/+ R26
Yfp/+ 
mice is largely restricted to the CD4
+ T cell lineage. (A) Relative accumulation of 
YFP expressing cells in secondary lymphoid organs of Tnfrsf4
Cre/+ R26
Yfp/+ mice over 
time. Symbols represent the mean values (±SEM) of 2-3 mice per time point per 
organ. (B) Frequency of CD4
+, CD8
+ or CD19
+ cells or cells negative for all three 
markers (other) in gated YFP
+ cells from the spleen and lymph nodes of Tnfrsf4
Cre/+ 
R26
Yfp/+ mice. Mean values (±SEM) of 9 mice are shown. 
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We next analysed which cell types in spleen and lymph nodes expressed YFP. Our 
analysis revealed that ~95% of YFP
+ cells were CD4
+ T cells whereas only 2% were 
CD8
+ T cells and 2% were B cells (Fig. 8-B), confirming the expected specificity of 
CD134 expression for CD4
+ T cells (Watts, 2005). 
 
We looked at expression of YFP in CD4
+ T cell subsets in spleen and lymph nodes. 
YFP expression in Tnfrsf4
Cre/+ R26
Yfp/+ mice marked ~ 55% and ~ 80% of memory 
and regulatory CD4
+ T cells, respectively. In contrast, the vast majority of naïve CD4
+ 
T cells (92%) were YFP
- (Fig. 9-B). In young adult mice, regulatory CD4
+ T cells 
constitute ~ 10% of total CD4
+ T, while the frequency of memory CD4
+ T is higher, 
particularly in the spleen, where they are twice as frequent as regulatory T cells, 
reaching more than 20% of  total CD4
+ T cells. Thus, in total numbers, the majority of 
cells expressing YFP in Tnfrsf4
Cre/+ R26
Yfp/+ mice were memory CD4
+ T cells. 
 
We next looked at CD8
+ T cells in more detail in both spleen and lymph nodes. We 
subdivided CD8
+ T cells in naïve and memory subsets by low or high expression of 
CD44, respectively (Fig. 9-C). This has been the classification used throughout this 
work. Although CD44 expression does not distinguish between true memory cells, 
that is antigen experienced cells, and ones that acquired phenotypic properties of 
memory cells, it is normally accepted to use CD44 expression to classify memory cell 
subsets. We observed that both naïve and memory CD8
+ T cells (99% and 97%, 
respectively) were YFP
- (Fig. 9-D).   77
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Specific targeting of memory and regulatory CD4
+ T cells in 
Tnfrsf4
Cre/+ R26
Yfp/+  mice. Flow cytometric example of subdivision of CD4
+ T cells 
into naïve (N, CD44
lowCD25
-), memory (M, CD44
highCD25
-) and regulatory (R, 
CD25
+) subsets (A), and of CD8
+ T cells into naïve (N, CD44
lowCD25
-) and memory 
phenotype (M, CD44
highCD25
-) cells (C). Percentage of YFP
+ cells in total, naïve, 
memory and regulatory CD4
+ (B) or in total, naïve and memory CD8
+ T cells (D) 
from the spleen and lymph nodes of Tnfrsf4
Cre/+ R26
Yfp/+ mice. Mean values (±SEM) 
of 9 mice are shown. 
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We further investigated whether YFP was expressed in non-lymphoid organs. We 
looked at peritoneal cavity, a site normally populated by activated cells, many (~50%) 
of which are macrophages. Although we saw an increase with age in the frequency of 
YFP
+ cells it was always less than 5% of total cells, and the vast majority were CD4
+ 
T cells (not shown). Analysis of lung and  liver showed no significant YFP expression 
(not shown).  
 
In summary, using this reporter line we have identified the cell populations that 
express YFP upon CD134 upregulation. YFP expression was observed almost 
exclusively in memory and regulatory CD4
+ T cells, the major targets of 
immunodeficiency virus. We did not see significant YFP expression in other immune 
cells nor in non-lymphoid organs. This is in agreement with published results where 
expression of CD134 was assessed by surface staining with anti-CD134 antibody 
(Takeda et al., 2004).     79
 
3.2. DTA-mediated deletion of CD134
+ CD4
+ T cells 
Having confirmed the suitability of the Tnfrsf4-Cre-mediated targeting of activated 
CD4
+ T cells, we generated a mouse strain in which these cells were being deleted. 
This was achieved by crossing the Tnfrsf4
Cre/Cre knock-in strain with the R26
Dta/+ 
transgenic strain, in which DTA expression under the R26 promoter is prevented by a 
floxed stop cassette. The progeny obtained was Tnfrsf4
Cre/+  R26
Dta/+ mice and 
Tnfrsf4
Cre/+  R26
+/+ littermate controls. In all experiments, littermate controls were 
included to rule out any potential Tnfrsf4 gene dose effect. 
 
We started by analyzing the efficiency of DTA-mediated deletion. For this purpose 
we generated mice expressing both DTA and YFP alleles in the R26 locus and named 
this heterozygous mice Tnfrsf4
Cre/+  R26
Yfp/Dta. Theoretically, if recombination and 
deletion are 100% efficient, these mice should have no YFP expressing cells. 
 
Our analysis revealed a 2.3- and 3- fold decrease in the total number of YFP 
expressing splenic and lymph node cells, respectively, in mice with both YFP and 
DTA alleles when compared with mice with YFP allele only (Fig. 10-A). The 
reduction in CD4
+ T cells was about 2.3- fold in both organs and paradoxically there 
were more YFP expressing CD8
+ T cells in mice with both alleles than in mice with 
YFP allele only (Fig. 10-A). The proportion of YFP expressing CD8
+ T cells in 
Tnfrsf4
Cre/+ R26
Yfp/Dta was nevertheless very small.   80
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. DTA-mediated deletion of YFP
+ CD4
+ T cells in Tnfrsf4
Cre/+ R26
Yfp/Dta 
mice. Percentage of YFP
+ cells in total, CD4
+ and CD8
+ T cells (A) or naïve, memory 
and regulatory (Reg.) CD4
+ T cells (B) from Tnfrsf4
Cre/+ R26
Yfp/Dta (YFP/DTA) mice 
and littermates Tnfrsf4
Cre/+ R26
Yfp/+ (YFP/+). Numbers represent the fold difference in 
frequencies of YFP
+ cells between YFP/+ and YFP/DTA mice. Mean values (±SEM) 
of 4 mice per group from 2 separate experiments are shown.  
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Analysis of the major YFP expressing populations, ie, memory and regulatory CD4
+ 
T cells, showed that in comparison with Tnfrsf4
Cre/+ R26
Yfp/+ mice, the proportion of 
YFP
+ memory and regulatory CD4
+ T cells in Tnfrsf4
Cre/+ R26
Yfp/Dta mice was reduced 
by more than half in both organs (Fig. 10-B).  
 
This result suggests that more than 50% of the cells tagged with YFP in the absence 
of DTA expression were killed upon DTA reactivation. However, this analysis 
ignores the dynamic nature of T cell death and replacement. In Tnfrsf4
Cre/+ R26
Yfp/+ 
mice the immune system is at steady-state, but in Tnfrsf4
Cre/+  R26
Yfp/Dta mice the 
killing of activated CD4
+ T cells leads to changes in T cell dynamics for both CD4
+ 
and CD8
+ T cells that are described in the following chapters. Consequently, the 
relative presence of activated CD4
+ T cells and proportion of YFP
+ T cells in 
Tnfrsf4
Cre/+ R26
Yfp/Dta mice reflect the balance between DTA-mediated killing, which 
reduces, and homeostatic replacement, which increases, the number of YFP
+ activated 
CD4
+ T cells. 
 
In addition to T cell dynamics, the interpretation of the proportion of YFP expressing 
cells in Tnfrsf4
Cre/+ R26
Yfp/Dta mice may also be influenced by the relative kinetics of 
YFP and DTA induction following T cell activation. YFP and DTA are different 
proteins and consequently may have a different kinetic of expression. For YFP 
expression to be detected, YFP simply needs to be expressed in the cytoplasm in 
sufficient amount to be revealed by flow cytometry. Similarly, for DTA-mediated 
deletion to be detected, DTA needs to be expressed in sufficient amount to kill a cell. 
DTA causes cell death by triggering the apoptosis (or programmed cell death) 
pathway (Lessnick et al., 1992; Chang et al., 1989).  Although it has been shown in   82
vitro that a single molecule is sufficient to kill a cell (Palmiter et al., 1987), it remains 
to be shown if this is true in vivo and for all cell types. In addition, cessation of 
protein synthesis and subsequent apoptosis are processes that take some time and thus 
the existence of YFP cells in the heterozygous mice could merely reflect the fact that 
cells have rearranged both alleles and are undergoing cell death but are not dead yet. 
In addition, it is plausible to consider that Cre-recombination could occur more easily 
in one allele than the other. These issues were addressed by comparing the kinetics of 
YFP and DTA induction following T cell activation in in vitro systems. 
 
To investigate YFP induction following activation, naïve CD134
- YFP
- CD4
+ T cells 
from Tnfrsf4
Cre/+ R26
Yfp/+ mice were sorted and stimulated in vitro with anti-CD3 and 
anti-CD28. We then compared the expression of CD134 and YFP by flow cytometry 
at different times. Cells begun to express YFP already in the first day of culture, with 
a delay of ~1 day in relation to CD134 induction (Fig. 11-A and 11-B), which 
achieved its maximal expression already at 24 hours and declined after 48 hours. This 
transient expression of CD134 in vitro is in agreement with previous studies 
(Gramaglia et al., 1998). 
 
We tested the kinetics of DTA-mediated cell death by looking at Annexin V, a marker 
of early apoptosis, by flow cytometry. Sorted CD25
- CD45RB
high naïve CD4
+ T cells 
from Tnfrsf4
Cre/+ R26
DTA/+ mice and littermate controls were stimulated in vitro with 
anti-CD3 and anti-CD28, and apoptosis was examined at different times. In the first 
24 hours post activation both groups of cells behaved in similar way, indicating that 
DTA was not yet active (Fig. 12-A and 12-B).    83
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11. Kinetics of YPF and CD134 induction in CD4
+ T cells upon in vitro 
stimulation. (A) Flow cytometric example of YPF and CD134 expression in 
unstimulated cells (0h) or after in vitro stimulation of sorted naïve YFP
- CD4
+ T cells 
from  Tnfrsf4
Cre/+  R26
Yfp/+ mice at the indicated time points after stimulation. 
Representative plots of 1 out of 3 separate experiments. (B) Kinetics of YPF and 
CD134 induction in CD4
+ T cells stimulated as in (A). The mean (±SEM) percentage 
CD134
+ and CD134
+YFP
+ cells in CD4
+ T cells from 4-6 mice from 3 separate 
experiments is shown. 
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Figure 12. Kinetics of apoptosis induction in CD4
+ T cells by DTA expression 
upon in vitro stimulation. (A) Flow cytometric example of annexin V expression in 
unstimulated cells (d0) or following in vitro activation of sorted naïve CD4
+ T cells 
from  Tnfrsf4
Cre/+  R26
Dta/+ (DTA) or control Tnfrsf4
Cre/+  R26
+/+ (WT) mice at the 
indicated time points after stimulation. (B) Kinetics of apoptosis induction following 
in vitro activation as in (A). The mean (±SEM) percentage of annexin V
+ cells in 
CD4
+ T cells from 3-5 mice from 2 separate experiments is shown. 
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However, by day 2, we could see that DTA-originated cells had a higher percentage 
of Annexin V
+ cells, which increased only slightly by day 3. In contrast, cells of WT 
origin decreased their percentage of apoptotic cells in culture (Fig. 12-A and 12-B), 
which reflects the proliferation of viable cells in the well. We concluded that the 
effect of DTA activation on survival of in vitro activated naïve CD4
+ T cells from 
Tnfrsf4
Cre/+ R26
Dta/+ mice was not evident until the second day of culture. 
 
In summary, DTA-mediated deletion is delayed by one day in relation to YFP 
induction. This has implications for the interpretation of the analysis of Tnfrsf4
Cre/+ 
R26
Yfp/Dta mice, because the percentage of YFP cells could reveal cells on their way to 
die. 
 
Overall, we can conclude by the analysis of the two reporter lines described that in 
Tnfrsf4
Cre/+ R26
Dta/+ mice a majority of memory and regulatory cells are deleted. The 
fact that this deletion might not be absolute is not an obstacle. On the contrary, it 
makes the system more physiological, given that in in vivo infections, viruses only kill 
a proportion of these cells.   86
3.3. Immunological consequences of DTA-mediated deletion 
of CD134
+CD4
+ T cells 
The Tnfrsf4
Cre/+ R26
Dta/+ mice are fertile and do not display any gross physical or 
behavioural abnormalities 
1. Upon macroscopic examination we observed significant 
lymph node enlargement in Tnfrsf4
Cre/+ R26
Dta/+ mice, in comparison with control 
Tnfrsf4
Cre/+ R26
+/+ mice (Fig. 13). Spleen size was not significantly different between 
the two groups. Microscopic examination of many non lymphoid tissues, including 
skin, kidney, lung, brain, salivary glands, stomach, liver, gall bladder, pancreas, small 
and large intestines showed no abnormalities, although mild lymphocytic infiltrates 
were sometimes observed in Tnfrsf4
Cre/+ R26
Dta/+ mice. Lymph nodes and spleen had 
normal follicular structure with active germinal centres and were architecturally 
indistinguishable from control mice (not shown). 
 
To see if the lymphoproliferation observed in lymph nodes was associated with a 
generalized proinflammatory status, we looked at serum levels of a panel of cytokines 
and chemokines by using a multiplex cytokine bead array. Indeed, we observed 
elevated serum levels of various proinflammatory cytokines (IL-1β, IL-5, Il-12p40, 
IL-13, IFNγ, TNFα and GM-CSF) and chemokines (IP-10, MIG, Eotaxin, MCP-1 and 
MIP-1α (Fig. 14).  
------------------------------------------------------------------------------------------------------- 
1 Occasionally, a very small proportion of mice showed retarded development already 
evident at weaning. These mice were excluded from further analysis. Pathology 
analysis was done in several organs from 3 young littermate mice of very small size 
and revealed exocrine pancreatic hypoplasia in all 3 mice but unremarkable remaining 
organs including endocrine pancreas. The exocrine pancreas produces and secretes the 
digestive enzymes necessary for digestion which can explain the animals’ small size. 
The cause of occasional developmental retardation in Tnfrsf4
Cre/+ R26
Dta/+ mice has 
not been further investigated.   87
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. Macroscopic examination of lymphoid tissue reveals 
lymphoadenopathy in Tnfrsf4
Cre/+ R26
Dta/+ mice. Size of inguinal (i), axillary (a), 
brachial (b), cervical (c), mesenteric (m) lymph nodes and spleen from Tnfrsf4
Cre/+ 
R26
Dta/+ (DTA) and control Tnfrsf4
Cre/+ R26
+/+ (WT) mice is shown.  
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Figure 14. Increased levels of serum proinflammatory chemokines and cytokines 
in Tnfrsf4
Cre/+ R26
Dta/+ mice. Serum levels of the cytokines IL-1β, IL-5, IL-12p40, 
IL-13,  IFNγ, TNFα and GM-CSF and of the chemokines IP-10 (CXCL10), MIG 
(CXCL9), Eotaxin (CCL11), MCP-1 (CCL2) and MIP-1α (CCL3) in Tnfrsf4
Cre/+ 
R26
Dta/+ (DTA) and control Tnfrsf4
Cre/+  R26
+/+ (WT) mice. Values are from two 
separate experiments and represent the mean (±SEM) of 5 or 7 mice per group, 
depending on the experiment. 
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To determine whether activated CD4
+ T cell deletion had any impact on lymphocyte 
population dynamics we compared lymphoid organ cellularity and composition in 
Tnfrsf4
Cre/+  R26
Dta/+ and control mice (Fig. 15). Consistent with the enlargement 
observed macroscopically, we saw an increase in absolute number of cells in lymph 
nodes. Spleen cellularity was not significantly different between the two groups (Fig. 
15-B). To account for differential distribution between enlarged lymph nodes and 
spleen we calculated the sum of lymphocyte and myeloid populations in both organs. 
B cells, but not T cells or myeloid cells, were more numerous in Tnfrsf4
Cre/+ R26
Dta/+ 
mice than in control Tnfrsf4
Cre/+ R26
+/+ mice and lymph node B cells were primarily 
responsible for this increase (Fig. 15-B). An increase in lymph node T cells and 
myeloid cells was also observed, in proportion to the increase in total lymph node 
cellularity (Fig. 15-B). 
 
Remarkably, total CD4
+ T cell numbers were only marginally reduced (Fig. 16-A), 
while total CD8
+ T cell numbers were elevated in Tnfrsf4
Cre/+  R26
Dta/+ mice, 
compared with Tnfrsf4
Cre/+  R26
+/+ mice (Fig. 16-A). This became statistically 
significant when plotted as CD4:CD8 ratio (Fig. 16-B). This ratio is highly conserved 
between animals of the same inbred strain and shows effects masked by animal to 
animal variation.   90
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. Lymphoid organ cellularity and composition in Tnfrsf4
Cre/+ R26
Dta/+ 
mice. (A) Representative FACS plots showing gating strategy for analysis of B cells, 
T cells and macrophages in spleen (upper panel) and lymph nodes (lower panel) in 
Tnfrsf4
Cre/+  R26
Dta/+ (DTA) and control Tnfrsf4
Cre/+  R26
+/+ (WT) mice. Numbers 
represent percentage of cells in gate. (B) Total cellularity and numbers of CD19
+ (B 
cells), CD4
+ and CD8
+ (T cells) and CD11b
+F4/80
+ (Mphi, macrophages) in the same 
mice, in spleen and lymph nodes in separate and pooled. Values represent the mean 
(±SEM) of 19-21 mice per group. 
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Figure 16. Decrease of CD4:CD8 ratio in Tnfrsf4
Cre/+ R26
Dta/+ mice. Numbers of 
CD4
+ and CD8
+ T cells (A) and CD4:CD8 ratio (B)  in Tnfrsf4
Cre/+ R26
Dta/+ (DTA) 
and control Tnfrsf4
Cre/+ R26
+/+ (WT) mice in spleen and lymph nodes in separate and 
pooled. Values represent the mean (±SEM) of 19-21 mice per group. 
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In order to investigate whether there was any fluctuation of numbers over time, we 
analysed mice of different ages. We did not observe any variation throughout a 6-
month observation period both in numbers of total CD4
+ (Fig. 17-A) and total CD8
+ 
(Fig. 17-B) T cell numbers, resulting in a stable CD4:CD8 ratio throughout the 
indicated period (Fig. 17-C) suggesting that total numbers were maintained 
irrespective of thymic output. 
 
In summary, deletion of activated CD4
+ T cells resulted in a lymphoproliferative 
condition accompanied by a substantial systemic drop in CD4:CD8 ratio, mainly due 
to a paradoxical increase of CD8
+ T cell numbers and, to a lesser extend, reduction in 
CD4
+ T cell numbers.   93
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 17. T cell cellularity in Tnfrsf4
Cre/+ R26
Dta/+ mice over time. Total numbers 
of CD4
+ (A), CD8
+ T cells (B) or CD4:CD8 ratio (C) in pooled lymph nodes and 
spleen of Tnfrsf4
Cre/+ R26
Dta/+ (DTA) and control Tnfrsf4
Cre/+ R26
+/+ (WT) mice at the 
indicated times after birth. Each symbol represents an individual mouse. Lines 
represent hyperbolic regression (DTA: dashed line, WT: solid line). 
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3.3.1. Effect of CD134
+ CD4
+ T cell-specific DTA induction on CD4
+ 
T cell homeostasis 
To assess whether activated CD4
+ T cell numbers were selectively reduced in 
Tnfrsf4
Cre/+  R26
Dta/+ mice, we measured the numbers and proportion of naïve, 
memory and regulatory CD4
+ T cells. Numbers of naïve CD4
+ T cells were similar 
between Tnfrsf4
Cre/+ R26
Dta/+ and control Tnfrsf4
Cre/+ R26
+/+ mice (Fig. 18-A and 18-
B). Notably, numbers of memory CD4
+ T cells were unchanged in the spleen and 
even elevated in the lymph nodes of Tnfrsf4
Cre/+ R26
Dta/+ mice, in comparison with 
control mice (Fig. 18-A and 18-B). Lastly, numbers of regulatory CD4
+ T cells were 
reduced in Tnfrsf4
Cre/+ R26
Dta/+ mice by ~ 40%, compared with those in control mice 
(Fig. 18-A and 18-B). 
 
Regulatory CD4
+ T cells in Tnfrsf4
Cre/+ R26
Dta/+ mice, identified by expression of 
CD25, expressed atypically high levels of CD44 (Fig. 18-A). CD25 is a marker that 
can be upregulated upon activation suggesting that these cells could be effectors 
rather than regulatory CD4
+  T cells. To exclude this possibility, we further 
characterized phenotypically this cell population. Regulatory T cells are characterized 
by the expression of the FoxP3 transcription factor (Hori et al., 2003; Fontenot et al., 
2003; Khattri et al., 2003)  and lower levels of the surface molecule CD4 (Sakaguchi 
et al., 2006; Fontenot et al., 2003; Khattri et al., 2003). We have thus analysed these 
parameters in the CD4
+CD25
+ population of Tnfrsf4
Cre/+ R26
Dta/+ mice. Similarly to 
regulatory CD4
+ T cells from normal mice, these cells expressed low levels of CD4 
and homogeneously expressed the regulatory T cell-specific FoxP3 transcription 
factor (Fig. 19-A and 19-B). 
   95
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18. Cellularity of CD4
+ T cell subsets in Tnfrsf4
Cre/+ R26
Dta/+ mice. (A) 
Flow cytometric profile and (B) absolute numbers of naïve, memory and regulatory 
(reg.) CD4
+ T cells from Tnfrsf4
Cre/+ R26
Dta/+ (DTA) and control Tnfrsf4
Cre/+ R26
+/+ 
(WT) mice in spleen and lymph nodes, in separate and pooled. Values represent the 
mean (±SEM) of 15-18 mice per group.  
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Figure 19. FoxP3 expression in CD4
+ T cells from Tnfrsf4
Cre/+ R26
Dta/+ mice. (A) 
Illustrative FACS plot of CD4 and CD25 expression in splenocytes gate. Numbers 
indicate the median fluorescence intensity (MFI) value for CD4 staining in quadrants 
(top). Illustrative FACS plot of FoxP3 intracellular staining in CD4
+  T cell gate. 
Numbers indicate percentage of FoxP3 expressing cells in quadrants (bottom). (B) 
Flow cytometry histograms of FoxP3 expression in naïve (N), memory (M) and 
regulatory (R) CD4
+ T cells. Numbers indicate percentage of FoxP3
+ cells. 
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We further analyzed their phenotypic differences from memory CD4
+ T cells (Fig. 
20-B and 20-C). Resting regulatory CD4
+ T cells are characterized by intermediate 
CD44 levels and the majority show high CD62L expression (Fisson et al., 2003). We 
have looked at these and other activation markers in the CD4
+CD25
+ population of 
Tnfrsf4
Cre/+ R26
Dta/+ mice. In contrast to regulatory CD4
+ T cells from control mice, 
those from Tnfrsf4
Cre/+  R26
Dta/+ mice displayed a highly activated phenotype, 
characterised by down-regulation of CD62L and up-regulation of CD43, CD49b, 
CD103 and CD127. This activation is even more pronounced than in the ‘memory’ 
regulatory population from control Tnfrsf4
Cre/+ R26
+/+ control mice (Fig. 21). 
 
Differences between memory CD4
+ T cells in Tnfrsf4
Cre/+  R26
Dta/+ and those in 
control Tnfrsf4
Cre/+ R26
+/+ mice were unremarkable with only modest increases in 
expression of CD43 and CD49b activation markers (Fig. 20-B). Regulatory T cells, in 
contrary to effector cells, are not expected to produce proinflammatory cytokines 
(Sakaguchi et al., 2006). We could hardly detect production of TNFα and IFNγ (Fig. 
20-C) and IL-2, IL-4, IL-10 and IL-17 (not shown) in this population. Memory cells, 
on the other hand, produced more IFNγ than controls, maybe reflecting their 
activation status (Fig. 20-B). 
 
In order to investigate the proliferative status of these cell populations, we analysed 
BrdU incorporation over a 6 days labelling period. Regulatory CD4
+ T cells showed 
an increased turnover in lymph nodes and spleen, whereas memory CD4
+ T cells in 
both organs were not significantly different when compared to controls (Fig. 22-B, 
22-C and 22-D).    98
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 20. Phenotype of CD4
+ T cell subsets from Tnfrsf4
Cre/+  R26
Dta/+ mice. 
Expression of activation markers and production of cytokines following in vitro 
restimulation in naïve (A), memory (B)  a n d  r e g u l a t o r y  (C) CD4
+ T cells in 
Tnfrsf4
Cre/+ R26
Dta/+ mice and littermate controls. Numbers within the plots represent 
the percentage of CD4
+ T cells which are positive for each marker (or negative in case 
of CD62L). Specifically in the CD127 staining, numbers indicated the median 
fluorescence intensity (MFI). Plots are representative of 4-7 mice per group. 
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Figure 21. CD4
+CD25
+CD44
bright  regulatory T cells from Tnfrsf4
Cre/+  R26
Dta/+ 
mice are more activated than those of control mice. Expression of activation 
markers was analysed separately on CD4
+CD25
+CD44
bright regulatory T cells. 
Numbers within the plots represent the percentage of cells that are positive for each 
marker (or negative in case of CD62L). Specifically for the CD127 staining numbers 
indicated the median fluorescence intensity (MFI). Plots are representative of 4-7 
mice per group. 
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Figure 22. Kinetics of CD4
+ T cell subsets in Tnfrsf4
Cre/+ R26
Dta/+ mice. Levels of 
BrdU incorporation after a 6-day administration period and expression of Ki67 
nuclear antigen on naïve (A), memory (B) and regulatory (C) CD4
+ T cells from 
Tnfrsf4
Cre/+ R26
Dta/+ (DTA) and control Tnfrsf4
Cre/+ R26
+/+ (WT) mice. BrdU
+ cells 
were gated according to staining levels in untreated mice. Ki67
+ cells were gated on 
MIF obtained with isotypic control. Each plot is representative of 6 mice (2 
independent experiments) for BrdU and 3 mice for Ki67 expression. Frequencies of 
BrdU
+ (D) and Ki67
+ (E) cells in lymph nodes and spleen. Values are the mean of 6 
(D) and 3 (E) mice per group. 
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To investigate if the apparent lack of accelerated turnover in the memory population 
was due to killing of dividing cells, cell division was analysed by the expression of 
Ki67 cell cycle antigen which gives a snapshot of cell turnover. Memory CD4
+ T cells 
of Tnfrsf4
Cre/+ R26
Dta/+ mice contained more Ki67+ cells then control mice, although 
the difference was only significant in the spleen (Fig. 22-B and 22-E). Regulatory 
CD4
+ T cells had considerably higher frequencies of dividing cells when compared to 
controls in both organs (Fig. 22-C and 22-E). 
 
In conclusion, despite higher expression of CD44, CD25
+CD4
+ T cells in Tnfrsf4
Cre/+ 
R26
Dta/+ mice were similar to regulatory CD25
+CD4
+ T cells in control mice but were 
more activated and had higher turnover rate. Furthermore, DTA-mediated destruction 
of activated CD4
+ T cells had a significant effect on regulatory CD4
+ T cell numbers 
and activation state, but little apparent effect on memory CD4
+ T cells. 
 
Memory CD4
+ T cells were deleted by DTA expression (by extrapolation of 
observations with Tnfrsf4
Cre/+ R26
Yfp/+ mice) as efficiently as regulatory CD4
+ T cells; 
one would therefore expect their numbers to be decreased but we observed the 
opposite. Memory CD4
+ T cells, under physiological conditions, display higher 
turnover rate, self-renewal potential and activation profile than either naïve or 
regulatory CD4
+ T cells, which could compensate for or mask DTA-mediated loss. To 
reveal the full extent of memory CD4
+ T cell killing in Tnfrsf4
Cre/+ R26
Dta/+ mice we 
set up mixed bone marrow (BM) chimeras.  
   102
Rag-deficient mice produce no mature B or T cells due to the deficiency in 
recombination activating gene (RAG), the enzyme necessary for antigen receptor 
gene rearrangement, which does not affect the development of other cell lineages. In 
theory, when bone marrow cells from Rag
+/+ mice are transferred into Rag
-/- 
recipients, lymphocyte precursors from both types of mice will have to compete with 
each other until the developmental stage at which RAG enzymes are expressed which 
is double negative 4 (DN4) stage – very early in development of these cells (Shinkai 
et al., 1992). Afterwards, Rag-sufficient cells have no competition and should be able 
to develop normally. For all other cell lineages, the transferred RAG-sufficient cells 
face a full host and therefore will have a competitive disadvantage and will not be 
reconstituted. Large numbers of BM cells (~20x10
6 cells) were transferred into non-
irradiated Rag2-deficient mice which were killed after 17 weeks and number of cells 
recovered calculated (Fig. 23-A). Donor and host-origin cells were discriminated by 
expression of CD45.2 and CD45.1 congenic markers, respectively. As shown in Fig. 
23-B and 23-C, reconstitution occurred exclusively in lymphoid lineages but not in 
myeloid lineages.  
 
Thus, although irradiation is common practice in bone marrow transplantation 
experiments, we show here that it is not necessary and that transferring high numbers 
of BM cells and giving enough time for reconstitution results in exclusive expansion 
of lymphocytes. The experiments described below were thus performed in non-
irradiated hosts.   103
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Exclusive reconstitution of lymphoid lineages in non-irradiated Rag-
deficient recipients reconstituted with WT bone marrow. (A) Total cell numbers 
recovered from the spleen, lymph nodes, thymus and peritoneal cavity (PC) of 
CD45.1 Rag2-deficient recipients 16 weeks after reconstitution with 20x10
6 BM cells 
from B6 mice. B6 and Rag1
-/- cell counts are shown for comparison. Flow cytometry 
plots showing reconstitution of lymphoid lineages (B) but not of myeloid lineages (C) 
in same chimeras as in A. Plots are representative of 3 mice. N.D: not done. 
Gated on CD11b+
in the peritoneal
cavity
98
Gated on Gr1+
in the spleen C
C
D
4
5
.
2
CD45.1
Gated on 
TCRα+
C
D
4
5
.
2
CD45.1
99.8
Gated on 
CD19+
99.7
B
106
107
108
Spleen Lymph
nodes
Thymus PC
A
N
.
D
.
C
5
7
B
L
/
6
R
a
g
 
-
/
-
1
3
C
h
i
m
e
r
a
2
C
5
7
B
L
/
6
R
a
g
 
-
/
-
1
3
C
h
i
m
e
r
a
2
C
5
7
B
L
/
6
R
a
g
 
-
/
-
1
3
C
h
i
m
e
r
a
2
C
5
7
B
L
/
6
R
a
g
 
-
/
-
1
3
C
h
i
m
e
r
a
2
C
5
7
B
L
/
6
R
a
g
 
-
/
-
1
3
C
h
i
m
e
r
a
2
C
5
7
B
L
/
6
R
a
g
 
-
/
-
1
3
C
h
i
m
e
r
a
2
C
5
7
B
L
/
6
R
a
g
 
-
/
-
1
3
C
h
i
m
e
r
a
2
C
5
7
B
L
/
6
R
a
g
 
-
/
-
1
3
C
h
i
m
e
r
a
2
95  104
To address the issue of memory CD4
+ T cell killing in Tnfrsf4
Cre/+ R26
Dta/+ mice, BM 
cells from CD45.1 wild-type and CD45.2 Tnfrsf4
Cre/+ R26
Dta/+ mice, mixed or on their 
own, were transferred into non-irradiated CD45.2 Rag1
-/- hosts. Reconstitution was 
monitored in the blood and twelve weeks post transfer mice were killed and analysed. 
Compared with recipients reconstituted with wild-type BM alone, those reconstituted 
with  Tnfrsf4
Cre/+  R26
Dta/+ BM alone showed a paradoxical increase in activated 
CD43
+ CD44
+ CD4
+ T cells and a small reduction in regulatory CD25
+CD4
+ T cells 
(Fig. 24-B). This is reminiscent of the phenotype observed in Tnfrsf4
Cre/+ R26
Dta/+ 
mice. For the analysis of mixed BM chimeras, we assessed the proportion of 
Tnfrsf4
Cre/+ R26
Dta/+ -derived cells by the lack of expression of CD45.1 marker. We 
extrapolated the ratio of injection/efficiency of reconstitution by the Tnfrsf4
Cre/+ 
R26
Dta/+: wild-type ratio in the thymus or in peripheral B cells and CD8
+ T cells 
(which should not be affected). As shown in Fig. 24-A, ~35% of cells in thymus and 
peripheral B cells and CD8 cells are of Tnfrsf4
Cre/+ R26
Dta/+ origin and ~65% are of 
WT origin. Notably, we observed a significant selective loss of Tnfrsf4
Cre/+ R26
Dta/+-
origin memory and regulatory CD4
+ T cells, but not in the naïve pool, in which both 
Tnfrsf4
Cre/+ R26
Dta/+-origin  and WT –origin contributed in the expected proportion 
(Fig. 24-A). 
 
Thus, by co-transferring Tnfrsf4
Cre/+ R26
Dta/+ and WT cells in the same host, we were 
able to reveal the full extend of the DTA-mediated deletion that occurs preferentially 
in memory and regulatory CD4
+ T cells.  105
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 24.  Loss of memory and regulatory CD4
+ T cells of DTA origin revealed 
in mixed bone marrow chimeras. CD45.2
+ Tnfrsf4
Cre/+ R26
Dta/+ (DTA) and CD45.1
+ 
C57BL/6 (B6) wild-type (B6) bone marrow (BM) cells were injected separately or 
mixed together (mixed BM chimeras) into non-irradiated Rag1
-/- recipients and 
lymphoid organs were analyzed 12 weeks later. (A) Mean (±SEM) percentage of 
DTA-origin (CD45.2
+) cells in thymocyte and peripheral lymphocyte subsets in 
mixed BM chimeras. (B) Expression of CD25, CD43 and CD44 on gated CD4
+ T 
cells from these chimeras is shown. Numbers represent percentage of cells within the 
quadrants. Values are representative of 4-8 mice analyzed in 2 independent 
experiments. 
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  Overall, our results showed that while both memory and regulatory CD4
+ T cell 
subsets were being killed with similar efficiency by DTA-activation, regulatory CD4
+ 
T cells were incompletely replenished while the loss of memory CD4
+ T cells was 
overcompensated. 
 
The result obtained with the Tnfrsf4
Cre/+ R26
Dta/+ BM chimeras has also excluded a 
potential role for ectopic or leaky expression of Cre or DTA in the phenotype of 
Tnfrsf4
Cre/+ R26
Dta/+ mice. Indeed, lymphocytes alone were able to recapitulate the 
homeostatic features observed in unmanipulated Tnfrsf4
Cre/+ R26
Dta/+ mice.   107
 
3.3.2. Partial CD4
+ T helper cell immune deficiency in Tnfrsf4
Cre/+ 
R26
Dta/+ mice 
To investigate whether the accelerated death and replenishment of effector/memory 
CD4
+ T cells compromised immune competence, we evaluated CD4
+ T cell function 
in Tnfrsf4
Cre/+ R26
Dta/+ mice in a number of infections. 
 
3.3.2.1. Immune response of Tnfrsf4
Cre/+ R26
Dta/+ mice to a chronic 
viral infection 
Friend virus (FV) is a murine retrovirus that causes persistent infection in resistant 
strains of mice. It preferentially infects erythroid precursor cells (Ter119
+ cells) but 
can also infect B cells and macrophages. CD4
+ T cells have been shown to play an 
indispensable role in the control of chronic infection with FV (Super et al., 1998). We 
have experimentally infected Tnfrsf4
Cre/+  R26
Dta/+ and control mice with FV and 
evaluated their ability to produce FV-specific neutralizing antibodies as an indirect 
measure of helper T cell function. In comparison to Tnfrsf4
Cre/+ R26
+/+ littermates and 
B6 control mice, which showed a strong nAb response to and effectively contained 
infection with FV, the FV-specific nAb response was undetectable in 4 out of 7 
Tnfrsf4
Cre/+ R26
Dta/+ mice and was significantly delayed in the rest (Fig. 25-A). Cell-
associated virus can be estimated by flow cytometric detection of infected cells using 
surface staining for the glycosylated product of the viral gag gene (glyco-Gag).    108
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 25. Impaired immune response to chronic viral infection in Tnfrsf4
Cre/+ 
R26
Dta/+ mice. Tnfrsf4
Cre/+ R26
Dta/+ (DTA) and littermate control Tnfrsf4
Cre/+ R26
+/+ 
(WT) and B6 (B6) mice were infected with Friend virus (FV). (A) Serum titers of 
virus-neutralizing antibodies were measured at indicated time points. Values are the 
mean (±SEM) of 5-7 mice tested in 2 independent experiments. P≤0.018 and P≤0.007 
on days 21 and 28, respectively, between DTA mice and either WT or B6 mice. (B) 
Cell-associated FV loads were determined 15 weeks after infection by staining for 
FV-encoded glyco-Gag on the surface of infected erythroid precursor (Ter119
+) cells. 
Numbers within quadrants represent the percentage of positive cells. Glyco-Gag
+ 
Ter119
+ cells were detected in 4 out of 7 Tnfrsf4
Cre/+ R26
Dta/+ mice and in 0 out of 6 
Tnfrsf4
Cre/+ R26
+/+ mice. 
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As shown in Fig. 25-B, infected cells could be detected in some Tnfrsf4
Cre/+ R26
Dta/+ 
mice but not in control mice 15 weeks after infection. The same mice that were unable 
to mount a strong Ab response were the ones that had not cleared the infection. 
 
In summary Tnfrsf4
Cre/+ R26
Dta/+ mice had defective FV-specific nAb response which 
correlated with inability to control FV replication. 
 
3.3.2.2. Immune response of Tnfrsf4
Cre/+ R26
Dta/+ mice to an acute 
viral infection 
Chronic viral infections, by their nature, create a continuous strain on the immune 
system which could have potentiated the effect of the deletion of activated cells in 
Tnfrsf4
Cre/+ R26
Dta/+ mice. We therefore assessed the response of these mice to an 
acute viral infection with the influenza A virus (IAV). CD4
+ T helper cell is crucial 
for the production of neutralizing antibodies by B cells in IAV infection (Gerhard et 
al., 1997) and TCRα
-/- mice, which lack T cells, are unable to produce high titres of 
nAb (Fig. 26-A). Titres of virus-neutralizing antibodies in the serum of Tnfrsf4
Cre/+ 
R26
Dta/+ mice were 2-fold and 2.7-fold reduced, compared with Tnfrsf4
Cre/+ R26
+/+ 
littermates and B6 mice, respectively, 18 days following IAV infection (Fig. 26-A).  
 
In IAV infection, production of nAbs is dependent on the provision of CD4
+ T helper 
cells. We therefore determined the number of CD4
+ T cells that were necessary to 
produce a titre equivalent to the one produced by Tnfrsf4
Cre/+  R26
Dta/+  mice. We 
transferred titrating amounts: 10%, 1%, 0.1% and 0.01% of total CD4
+ T cells in 
normal B6 mice, as described in materials and methods, into TCRα
-/- and infected 
them with IAV.   110
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 26. Impaired immune response to acute viral infection in Tnfrsf4
Cre/+ 
R26
Dta/+ mice. (A) Tnfrsf4
Cre/+ R26
Dta/+ (DTA), littermate controls Tnfrsf4
Cre/+ R26
+/+ 
(WT), B6 and TCRα
-/- mice were infected with Influenza A virus (IAV). Serum titers 
of virus-neutralizing antibodies were measured at indicated time points. Values are 
the mean (±SEM) of 6-9 mice tested in 3 independent experiments. P=0.002 between 
DTA and WT mice and P=0.00003 between DTA and B6 mice on day 18. (B) Titers 
of IAV-neutralizing antibodies in the serum of T cell-deficient TCRα
-/- mice, which 
received titrated numbers of CD4
+ T cells from wild-type B6 donor mice one day 
before IAV infection, are shown. Sera were tested 18 days post IAV infection. The X 
axis depicts the number of adoptively transferred CD4
+ T cells, on the day of the 
transfer, expressed as a percentage of the total number of CD4
+ T cells in wild-type 
B6 mice (100%). Symbols represent the mean (±SEM) of 3-4 mice.   
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Eighteen days later, we compared the nAb titres produced by each group receiving 
different numbers of CD4
+ T cells with the titres produced by Tnfrsf4
Cre/+ R26
Dta/+ 
mice (Fig. 26-A and  26-B). This experiment revealed that the degree of reduction in 
IAV-specific nAb titers in Tnfrsf4
Cre/+ R26
Dta/+ mice corresponded to ~80% loss of 
CD4
+ T cells. 
 
3.3.2.3. Immune response of Tnfrsf4
Cre/+ R26
Dta/+ mice to a fungal 
infection 
In humans, Pneumocystis carinii pneumonia (PCP) is a common clinical problem in 
immune compromised individuals, including HIV patients and there is a clear 
correlation between CD4
+ T cell counts and the risk of PCP (Hanano and Kaufmann, 
1998). In mice, Pneumocyctis murina ( P. murina), an opportunistic pulmonary 
pathogen, can cause pneumonia in immune deficient mice with features resembling 
PCP in humans. Mutant mice deficient in lymphocytes (Rag
-/-), T cells (TCRβ
-/-) or 
CD4
+ T cells (MHC II
-/-) have been shown to be extremely susceptible to P. murina 
pneumonia (Hanano et al., 1996). In contrast, immunocompetent  mice or mice 
deficient in CD8
+ T cells (β2m
-/-) are fully resistant to natural infection (Hanano et al., 
1996), revealing the central role of CD4
+ T cells in controlling P. murina infection. 
 
We compared the immune response of Tnfrsf4
Cre/+  R26
Dta/+ mice and Tnfrsf4
Cre/+ 
R26
+/+ controls to experimental P. murina infection with respect to pulmonary 
inflammation and pathogen clearance. As positive and negative controls for the 
infection, we included MHC II
-/- mice and B6 mice, respectively. Between week 10 
and week 17 after infection, Tnfrsf4
Cre/+ R26
Dta/+ mice failed to gain weight, while 
MHC II
-/- mice had a more pronounced weight loss. Control Tnfrsf4
Cre/+ R26
+/+ and   112
B6 mice gained weight steadily during this period. Mice were killed and analysed 17 
weeks post infection. Histologically, lung sections from B6 and Tnfrsf4
Cre/+ R26
+/+ 
controls were unremarkable. All MHC II
-/- mice analysed showed moderate to diffuse 
interstitial pneumonia with numerous intralesional organisms present whereas only 
one out of 4 Tnfrsf4
Cre/+  R26
Dta/+ mice analysed showed a moderate multifocal 
interstitial pneumonia, without evidence of organisms present in H&E stain or 
Gomori’s silver stain. PCR analysis was performed to detect numbers of organisms 
below histological detection levels. Using a standard PCR reaction, Pneumocystis 
specific DNA was detected exclusively in lung homogenates of MHC II
-/- mice but 
not in other groups of mice. However a nested PCR reaction, setup with the first PCR 
product as template, revealed the presence of Pneumocystis in all Tnfrsf4
Cre/+ R26
Dta/+ 
-origin DNA analysed. In summary, all four Tnfrsf4
Cre/+ R26
Dta/+ mice were positive 
for Pneumocystis either by histology or by PCR.  
 
Thus, even though Tnfrsf4
Cre/+ R26
Dta/+ mice did not develop pneumonia as did MHC 
II
-/-mice (Fig. 27-A), they were not free of P. murina organisms (Fig. 27-B). This was 
in contrast to littermate controls and B6 mice, in which there was no evidence for the 
presence of P. murina organisms. 
 
 
Taken together, these results showed that, despite the presence of normal numbers of 
CD4
+ T cells, Tnfrsf4
Cre/+ R26
Dta/+ mice were partially CD4
+ T cell-immune deficient.   113
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. Immune response of Tnfrsf4
Cre/+ R26
Dta/+ mice to Pneumocystis murina 
infection. Tnfrsf4
Cre/+ R26
Dta/+ (DTA), littermate control Tnfrsf4
Cre/+ R26
+/+ (CRE), 
B6 and MHCII
-/- mice were infected with Pneumocystis murina. (A) Body weight as 
percentage of change in relation to weight at 10 weeks post infection is shown (mean 
±SEM). P=0.019 and P=0.033 between DTA and CRE or B6 mice, respectively, at 
week 17 (B) Representative lung histological sections after hematoxylin and eosin 
staining. 100x magnification. (C) Detection of Pneumocystis murina rRNA by 
standard and nested PCR.  
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3.3.3. Effect of DTA-mediated deletion of CD134
+CD4
+ T cells on 
the homeostasis of B cells, macrophages and CD8
+ T cells 
 
3.3.3.1. B lymphocytes 
HIV infection is associated with increased immune activation that affects all 
lymphocyte populations. Polyclonal hypergammaglobulinemia, defective humoral 
immunity, expansion in B-cell areas of lymphoid tissues and increased expression of 
activation, proliferation and differentiation markers are all features of B lymphocytes 
in HIV untreated individuals (Moir and Fauci, 2008). 
 
We thus assessed whether B cells in Tnfrsf4
Cre/+  R26
Dta/+ mice showed signs of 
activation. We observed a comparable number of activated B cells (CD70
+ cells) in 
Tnfrsf4
Cre/+ R26
Dta/+ mice and controls (data not shown) and both groups of mice 
expressed equivalent levels of MHC II as evaluated by MFI (data not shown), 
excluding B cell activation in Tnfrsf4
Cre/+  R26
Dta/+ mice. Moreover, there was no 
detectable difference between serum levels of both IgM and IgG isotypes between 
both groups of mice (Fig. 28-A). 
 
To determine whether the increased number of B cells observed in the lymph nodes of 
Tnfrsf4
Cre/+ R26
Dta/+ mice (Fig. 15) was associated with increased proliferation we 
measured BrdU incorporation. As shown in Fig. 28-B, the frequency of dividing B 
cells was similar in both groups. In addition, we did not observe any difference 
between the two groups with respect to the frequency of Ki67
+ B cells (not shown).   115
As B cells were more numerous in Tnfrsf4
Cre/+ R26
Dta/+ mice than in controls, overall 
there was an increased number of dividing B cells in Tnfrsf4
Cre/+ R26
Dta/+ mice which 
however did not reach statistical significance.  
 
To assess the composition of the B cell pool, we looked at germinal centre B cells. 
These are cells that proliferate rapidly and
 at the same time acquire the capacity to 
undergo somatic hypermutation
 and isotype switching. They can be phenotypically 
characterized as B220
+ CD19
+ IgD
- CD38
low GL7
+. Tnfrsf4
Cre/+ R26
Dta/+ mice had a 
higher frequency of these cells (Fig. 28-C) and higher numbers (Fig. 28-D) in the 
lymph nodes but not in spleen. 
 
In summary, immune activation in the B cell compartment of Tnfrsf4
Cre/+ R26
Dta/+ 
mice seemed to affect exclusively germinal centre B cells, but did not seem to impact 
on the production of immunoglobulins nor on the cell division rate of B cells.   116
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. Analysis of B cells in Tnfrsf4
Cre/+ R26
Dta/+ mice. (A) Serum levels of IgM 
and IgG in  Tnfrsf4
Cre/+ R26
Dta/+ (DTA) and control Tnfrsf4
Cre/+ R26
+/+ (WT) mice. 
Each symbol represents an individual mouse. (B) Frequency and absolute numbers of 
BrdU
+ cells in lymph nodes from DTA and WT mice. (C) Flow cytometry of lymph 
node cells showing gating strategy to analyze germinal centre (CD38
low GL7
+) B cells. 
IgD
- cells gated on B220
+CD19
+ were analyzed for cell expression of CD38 and GL7 
(left). (D) Absolute numbers of germinal centre B cells in spleen and lymph node 
cells in DTA and WT mice. Numbers within the plots in (B and C) denote the 
percentage of positive cells in indicated gates and values in graphs (B and D) 
represent the mean (±SEM) of 4 mice or 6 mice per group, respectively. 
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3.3.3.2. Macrophages  
Although the number of macrophages in lymph nodes of Tnfrsf4
Cre/+ R26
Dta/+ was 
increased compared to control mice (Fig. 15-B), this was proportional to the increase 
in the organ size. Examination of macrophages (CD11b
+ F4/80
+) revealed no major 
differences between Tnfrsf4
Cre/+ R26
Dta/+ and control mice in terms of expression of 
the activation marker CD70 and intensity of MHC-II staining (not shown). 
 
3.3.3.3. CD8
+ T lymphocytes 
CD8
+ T cells in HIV infection are increased in numbers and also display higher 
turnover rate and activation state (Papagno et al., 2004; Giorgi et al., 1999; Hazenberg 
et al., 2003; Deeks et al., 2004). We therefore assessed whether the increase in CD8
+ 
T cell numbers in Tnfrsf4
Cre/+ R26
Dta/+ mice was also associated with higher activation 
and turnover. 
 
Elevated numbers of total CD8
+ T cells in Tnfrsf4
Cre/+ R26
Dta/+ mice, compared with 
control mice, were due exclusively to a systemic expansion of memory CD8
+ T cells 
(Fig. 29).  
 
Notably, compared with the relatively homogeneous memory CD8
+ T cell population 
in control mice, memory CD8
+ T cells in Tnfrsf4
Cre/+ R26
Dta/+ mice contained higher 
numbers of recently activated/effector CD8
+ T cells, characterized by down-
regulation of CD62L and up-regulation of CD43 expression (Fig. 30-A). The 
expanded memory CD8
+ T cells in Tnfrsf4
Cre/+ R26
Dta/+ mice showed a pattern of   118
cytokine production similar to those in memory CD8
+ T cells from control mice (Fig. 
30-B). Moreover, the rate of turnover of this population, evaluated by BrdU 
incorporation and Ki67 expression, was similar to control mice (Fig. 30-D). Since 
cytokine-producing proliferating T cells are restricted in the memory T cell pool, 
overrepresentation of memory CD8
+ T cells in Tnfrsf4
Cre/+  R26
Dta/+ mice was 
responsible for the higher activation state of the total CD8
+ T cell population in these 
mice (Fig. 30-C).  
 
To examine whether expansion of memory CD8
+ T cells in Tnfrsf4
Cre/+ R26
Dta/+ mice 
was a consequence of accelerated activated CD4
+ T cell turnover or a cell-
autonomous effect of DTA expression, we examined CD8
+ T cells in the BM 
chimeras described in chapter 3.3.1. 
 
Compared with mice reconstituted with wild-type BM alone, mice reconstituted with 
Tnfrsf4
Cre/+  R26
Dta/+ BM alone had significantly elevated percentages of memory 
CD8
+ T cells, which also contained higher percentages of CD62L
- and CD25
+ 
activated/effector CD8
+ T cells (Fig. 31-A), and reduced CD4:CD8 ratios (Fig. 31-B). 
In contrast, in mice reconstituted with a mixture of wild-type and Tnfrsf4
Cre/+ R26
Dta/+ 
BM , CD8
+ T cells of either wild-type- or Tnfrsf4
Cre/+  R26
Dta/+ BM-origin were 
comparable, with no signs of activation, and CD4:CD8 ratios were restored (Fig. 31-
A and 31-B).   119
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29. Composition of CD8
+ T cells in Tnfrsf4
Cre/+ R26
Dta/+ mice. (A) Flow 
cytometric profile and (B) absolute numbers of naïve and memory CD8
+ T cells from 
Tnfrsf4
Cre/+ R26
Dta/+ (DTA) and control Tnfrsf4
Cre/+ R26
+/+ (WT) mice in lymph node 
and  spleen, separate and pooled. Numbers within the plots in (A) denote the 
percentage of positive cells and values in (B) represent the mean (±SEM) of 15-18 
mice per group. 
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Figure 30. Phenotype and turnover of memory CD8
+ T cells in Tnfrsf4
Cre/+ 
R26
Dta/+ mice. (A) CD62L and CD43 expression in gated memory CD8
+CD44
hi T 
cells from Tnfrsf4
Cre/+ R26
Dta/+ (DTA) and control Tnfrsf4
Cre/+ R26
+/+ (WT) mice. 
Numbers within the plots denote the percentage of positive cells. (B) TNF-α and IFN-
γ production by memory CD8
+CD44
hi T cells from the same mice. Numbers within 
the quadrants represent the percentage of the respective cytokine secreting cells and 
are representative of 4 mice per group. (C) Percentage of BrdU
+ following a 6-day 
period of BrdU administration and Ki67
+ cells in total CD8
+ T cells in Tnfrsf4
Cre/+ 
R26
Dta/+ (DTA) and control Tnfrsf4
Cre/+  R26
+/+ (WT) mice. Values are the mean 
(±SEM) of 4 or 3 mice per group, respectively. (D) BrdU
 and Ki67 labelling in gated 
memory CD8
+CD44
hi T cells from the same mice. Numbers within the plots represent 
the percentage of positive cells for BrdU or Ki67 and are representative of 4 mice or 3 
miceper group, respectively. 
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In conclusion, the expansion and activation of memory CD8
+ T cells seen in 
Tnfrsf4
Cre/+ R26
Dta/+ mice was an indirect result of altered CD4
+ T cell homeostasis. 
We should therefore expect to see a similar phenotype in mice with primary CD4
+ T 
cell immunodeficiency, such as MHC II-deficient mice. MHC II-deficient mice, in 
which generation of CD4
+ T cells is blocked in the thymus, exhibited a proportional 
increase in numbers of both naïve and memory CD8
+ T cells and the representation of 
memory CD8
+ T cells was therefore similar to wild-type mice (Fig. 32-A and 32-B). 
Nevertheless, as was the case with Tnfrsf4
Cre/+ R26
Dta/+ mice, memory CD8
+ T cells in 
MHC II-deficient mice contained higher percentages of CD62L
- and CD43
+ 
activated/effector CD8
+ T cells, than wild-type mice (Fig. 32-C).   122
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 31. CD8 phenotype in Tnfrsf4
Cre/+ R26
Dta/+ mice is not cell intrinsic. Bone 
marrow chimeras, set up as in Fig. 18, were evaluated for the percentage of memory 
(CD44
hi) and effector (CD44
hiCD25
+) CD8
+ T cells (A, top row) or the percentage of 
CD62L
- cells in gated CD44
hiCD8
+ T cells (A, bottom row), or the mean (±SEM) 
CD4:CD8 ratio (B). Values are representative of 4-8 mice analyzed in 2 independent 
experiments. 
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Figure 32. Composition and phenotype of CD8
+ T cells in mice with primary 
CD4
+ T cell immune deficiency. (A) Percentage and (B) absolute number (mean 
±SEM of 4-6 mice) of naïve and memory CD8
+ T cells in MHC II
-/- and wild-type 
control (WT) mice. (C) CD62L and CD43 expression in gated memory CD44
hiCD8
+ 
T cells from the same mice. Numbers within the plots in (A) and (C) represent the 
percentage of cells which are positive for each marker and are representative of 4-6 
mice. 
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3.4. Immune activation is neither a consequence of self-
reactivity to apoptotic T cells nor of bacterial translocation 
Although the precise causes of immune activation in HIV infection are not entirely 
clear, two distinct mechanisms have recently been proposed, namely self-reactivity to 
apoptotic T cells (Rawson et al., 2007) and translocation of microbial products in the 
intestinal mucosa (Brenchley et al., 2007). 
 
Reactivity to apoptosis-related self-peptides could be excluded as the cause of CD8
+ T 
cell activation in Tnfrsf4
Cre/+  R26
Dta/+ mice as activation of these cells was not 
observed in mixed BM chimeras in the presence of wild-type CD4
+ T cells (Fig. 31-
A), despite continuous apoptosis of Tnfrsf4
Cre/+ R26
Dta/+ CD4
+ T cells.  
 
Although we found no evidence for intestinal pathology in Tnfrsf4
Cre/+ R26
Dta/+ mice 
it could be possible that a small degree of histologically undetectable bacterial 
translocation was occurring. To address this issue, we examined the effect of 
microbial translocation on the immune system of mice. Villin promoter-driven Cre-
mediated intestinal epithelial cell-specific deletion of NEMO (encoded by Ikbkg) 
leads to epithelial cell apoptosis, translocation of bacteria into the mucosa and TLR-
dependent intestinal inflammation and colitis (Nenci et al., 2007). We therefore 
assessed the immune activation status in the Ikbkg
fl/- Vil-Cre (NEMO) mice. 
 
Lymph nodes in Ikbkg
fl/-  Vil-Cre mice were enlarged and contained increased 
numbers of both B and T lymphocytes, compared with Ikbkg
fl/- littermate control mice   125
(Fig. 33-A and 33-B). This however, was at the expense of splenic lymphocytes (Fig. 
33-B) and overall numbers of B cell and CD4
+ and CD8
+ T cell subsets and the 
CD4:CD8 ratio in Ikbkg
fl/- Vil-Cre mice were normal (Fig. 33-A, 34-A and 34-B). 
Compared with Ikbkg
fl/- control mice, increased percentages and absolute numbers of 
memory CD4
+ and CD8
+ T cells were observed in enlarged lymph nodes but not in 
the spleens of Ikbkg
fl/- Vil-Cre mice (Fig. 35-A, 35-B, 36-A and 36-B ). In contrast to 
lymphocytes, numbers of CD11b
+F4/80
+ myeloid cells were dramatically elevated in 
all secondary lymphoid organs of Ikbkg
fl/- Vil-Cre mice and outnumbered B cells or T 
cells (Fig. 33-B). Thus, microbial translocation in this mouse model was associated 
with systemic expansion of myeloid cells, rather than memory CD8
+ T cells.   126
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 33. Effect of microbial translocation through the intestinal mucosa on 
lymphoid organ cellularity and composition. (A) Flow cytometric profile of 
CD11b
+F4/80
+ macrophages in Ikbkg
fl/- Vil-Cre (NEMO) and control Ikbkg
fl/- (WT) 
mice lymph nodes. (B) Total cellularity and numbers of B220
+ (B cells), CD4
+ and 
CD8
+ (T cells) and CD11b
+F4/80
+ (Mphi, macrophages) in spleen and lymph nodes 
separate and pooled. Values represent the mean (±SEM) of 9-11 mice per group. 
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Figure 34. Effect of microbial translocation through the intestinal mucosa on 
cellularity of CD4
+ and CD8
+ T cells. Numbers of CD4
+ or CD8
+ T cells and 
CD4:CD8 ratio in Ikbkg
fl/- Vil-Cre (NEMO) and control Ikbkg
fl/- (WT) mice in spleen 
and lymph nodes, in separate and pooled. Values represent the mean (±SEM) of 9-11 
mice per group. 
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Figure 35. Effect of microbial translocation through the intestinal mucosa on 
composition of CD4
+ T cells. (A) Percentages and (B) absolute numbers of naïve, 
memory and regulatory (reg.) CD4
+ T cells from Ikbkg
fl/-  Vil-Cre (NEMO) and 
control Ikbkg
fl/- (WT) mice in spleen and lymph nodes separate and pooled. Values 
represent the mean (±SEM) of 9-11 mice per group. 
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Figure 36. Effect of microbial translocation through the intestinal mucosa on 
composition of CD8
+ T cells. (A) Percentages and (B) absolute numbers of naïve and 
memory CD8
+ T cells from Ikbkg
fl/- Vil-Cre (NEMO) and control Ikbkg
fl/- (WT) mice 
in spleen and lymph nodes separate and pooled. Values represent the mean (±SEM) of 
9-11 mice per group. 
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3.5. Immune activation is a consequence of CD4
+ regulatory T 
cell homeostatic disturbances  
Our results argued against self-reactivity to apoptotic products or translocation of 
microbial products as the causes of immune activation in Tnfrsf4
Cre/+ R26
Dta/+ mice 
and instead supported immune activation as a direct consequence of CD4
+ T cell 
death. 
 
To explore the mechanism by which activated CD4
+ T cell deficiency leads to CD8
+ 
T cell activation, we reconstituted selected subsets of CD4
+ T cells affected in 
Tnfrsf4
Cre/+ R26
Dta/+ mice. The regulatory subset of CD4
+ T cells is targeted by HIV, 
SIV and FIV (Oswald-Richter et al., 2004; Pereira et al., 2007; Joshi et al., 2004), 
leading to enhanced turnover and activation, and a relative deficit in this subset has 
been linked by certain studies to immune activation and disease progression in HIV 
infection (Kinter et al., 2004; Eggena et al., 2005). 
 
Purified wild-type regulatory CD4
+ T cells (CD4
+ CD25
bright) adoptively transferred 
into  Tnfrsf4
Cre/+  R26
Dta/+ mice expanded efficiently, reaching numbers comparable 
with those of regulatory CD4
+ T cells in wild-type mice, and maintained their FoxP3 
expression (Fig. 37-A and 37-B). In contrast, the same cells transferred into 
regulatory CD4
+ T cell-replete control mice failed to expand (Fig. 37-A and 37-B).    131
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 37. Adoptively transferred wild type regulatory CD4
+ T cells expand in 
Tnfrsf4
Cre/+ R26
Dta/+ but not in control Tnfrsf4
Cre/+ R26
+/+mice. Tnfrsf4
Cre/+ R26
Dta/+ 
(DTA) and control Tnfrsf4
Cre/+  R26
+/+ (WT) mice received 1-3 × 10
6 purified 
regulatory CD25
+CD4
+ T cells from CD45.1-congenic B6 donor mice. Expansion of 
transferred cells was followed in the blood of recipient mice (A), and expansion and 
retention of Foxp3 expression in donor CD45.1
+CD4
+ T cells was assessed in 
lymphoid organs at the end of a 10-week observation period (B). Values represent the 
mean (±SEM) of 7-9 mice per group pooled from 3 independent experiments. 
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The adoptively transferred regulatory CD4
+ T cells had a significant effect on the 
proportion of memory CD8
+ T cells in the blood (Fig. 38-A) and lymphoid tissues 
(Fig. 38-B) of Tnfrsf4
Cre/+  R26
Dta/+ mice, particularly those with an activated 
CD44
hiCD62L
- phenotype, which were reduced to wild-type levels over a period of 
three weeks (Fig. 38-C and 38-D). Thus, CD8
+ T cell immune activation in 
Tnfrsf4
Cre/+ R26
Dta/+ mice is due to a deficit in regulatory CD4
+ T cell function.  
 
Furthermore, transfer of regulatory T cells had an effect on the serum levels of some, 
but not all, proinflammatory cytokines and chemokines. Serum levels of IL-1β, IFNγ, 
MCP-1 (CCL2) and MIP-1α (CCL3) were restored to levels in control Tnfrsf4
Cre/+ 
R26
+/+ (Fig. 39).   133
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38. Effect of regulatory CD4
+ T cell transfer on proportion and 
phenotype of memory CD8
+ T cells. (A) Percentage of memory (CD44
hi) cells in 
CD8
+ T cells in the blood of Tnfrsf4
Cre/+  R26
Dta/+ (DTA) and control Tnfrsf4
Cre/+ 
R26
+/+ (WT) mice, following transfer of 1-3 × 10
6 purified regulatory CD25
+CD4
+ T 
cells from CD45.1-congenic B6 donor mice. (B) Percentage of memory (CD44
hi) cells 
in CD8
+ T cells isolated from the spleen and lymph nodes of the same recipient mice 
(+ Treg), 10 weeks after transfer, or mice which did not receive CD25
+CD4
+ T cells (- 
Treg). (C) Percentage of effector/memory (CD62L
-CD44
hi) cells in CD8
+ T cells in 
the blood of the same recipients of regulatory CD25
+CD4
+ T cells. (D) Percentage of 
effector/memory (CD62L
-CD44
hi) cells in CD8
+ T cells isolated from the spleen and 
lymph nodes of the same recipient mice (+ Treg), 10 weeks after transfer, or mice 
which did not receive CD25
+CD4
+ T cells (- Treg). Values represent the mean 
(±SEM) of 7-9 mice per group pooled from 3 independent experiments.  
AB
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Figure 39. Effect of regulatory CD4
+ T cell transfer on serum levels of 
proinflammatory cytokines and chemokines in Tnfrsf4
Cre/+ R26
Dta/+ mice. Serum 
levels of the cytokines IL-1β and IFNγ, and of the chemokines MCP-1 (CCL2) and 
MIP-1α (CCL3) in Tnfrsf4
Cre/+ R26
Dta/+ (DTA) and control Tnfrsf4
Cre/+ R26
+/+ (WT) 
mice and after transfer of purified regulatory T cells from CD45.1-congenic B6 donor 
mice. Values represent the mean (±SEM) of 5 mice per group, pooled from two 
independent experiments. 
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4. Discussion 
 
In the present study we have induced conditional ablation of activated CD4
+ T cells, 
the targets of immunodeficiency viruses, in a virus-free murine system. Depletion of 
these cells affects memory/effector and regulatory CD4
+ T cells and leads to a 
disturbance in immune system homeostasis that shares many features with cell 
dynamics characteristic of HIV-1 infection. Specifically, partial deletion of 
memory/effector and regulatory CD4
+ T cells results in generalized immune 
activation characterized by enlarged lymph nodes, increased production of 
proinflammatory cytokines and chemokines, decrease in the CD4:CD8 ratio and 
increased activation and turnover of CD4
+ and CD8
+ T cells. Furthermore the immune 
response of these mice to a number of pathogens tested is impaired even though CD4
+ 
T cell numbers are relatively preserved. By separating killing from other viral-
mediated effects, we show that deficiency in regulatory T cells is sufficient to cause 
CD8
+ T cell immune activation.  
 
4.1. Conditional mutagenesis in the mouse 
The success of the Cre-loxP technology is dependent upon tight regulation of Cre 
expression so that it is only expressed in the intended cells. In this respect, the 
Tnfrsf4
Cre/+  mouse line used in this study has the advantage of having Cre inserted 
into the endogenous CD134 locus, thereby eliminating position effect variegation 
sometimes observed in the classical transgenesis approach (Kioussis and Festenstein, 
1997). In addition, by using a reporter line for Cre-mediated recombination, we were 
able to confirm that the expression of Cre in peripheral lymphoid tissues is restricted   136
almost exclusively to memory and regulatory CD4
+ T cell subsets, as expected. 
Because the removal of the stop signal is a permanent genetic modification all cells 
that have expressed but subsequently downregulated CD134 and all daughter cells 
will therefore express the reporter marker YFP. It is thus likely that the proportion of 
YFP
+ cells in the reporter line is an overrepresentation of the number of activated 
cells at any one moment. Importantly, we did not detect YFP expression in any other 
tissues analysed, indicating that Cre expression is tightly regulated in the Tnfrsf4
Cre/+ 
line. Although we cannot exclude the expression of Cre in other non-hematopoietic 
tissues that we did not analyse, we were able to show that the phenotype we are 
reporting is not due to ectopic expression but rather is immune cell-dependent, and 
could be reproduced by transfer of hematopoietic cells in Rag
-/- mice. 
 
It has been shown that CD134 can be up-regulated in CD8
+ T cells that are activated 
in vitro through TCR stimulation (Baum et al., 1994), but the absence of YFP
+ cells in 
the CD8
+CD44
+ fraction of Tnfrsf4
Cre/+  R26
Yfp/+ mice indicates that, under 
physiological conditions, the majority of memory-phenotype CD8
+ T cells will not 
receive the amount of stimulation that in vitro TCR stimulation delivers. However, in 
Tnfrsf4
Cre/+ R26
Yfp/Dta mice, where the CD8
+ T cell population is activated, we did see 
a small fraction of CD8
+ YFP
+. Because these cells also express DTA, this reporter 
strain does not permit evaluation of the true extent of CD8
+ T cells that upregulated 
CD134. Importantly however, we have several lines of evidence that activation of 
CD8
+ T cells is secondary to the CD4
+ T cell phenotype we described. Firstly, CD8
+ 
T cells are maintained in mixed bone marrow chimeras and are not activated. 
Secondly, in MHCII
-/- mice the absence of CD4
+ T cells results in CD8
+ T cell 
activation. Lastly, transfer of regulatory CD4
+ T cells is able to correct the CD8
+ T   137
cell activation phenotype. Thus we can rule out DTA-mediated depletion of CD8
+ T 
cells as contributing to their activated phenotype. 
 
With respect to the relevance of this system in our attempts to mimic CD4
+ T cell-
specific deletion by HIV, a number of points should be taken into account.  
 
First, the kinetics of DTA-mediated depletion we observe is similar to the one 
estimated for cells infected with HIV. It is calculated that HIV has an eclipse time of 
~1 day  between cell entry and virion production (Perelson et al., 1996), and that 
productively infected cells have a lifespan of ~1 day (Markowitz et al., 2003). Thus it 
takes ~2 days for HIV to kill a cell from the moment of cell entry. Similarly, we have 
shown that it takes approximately one day for the cell to express CD134 after 
activation and that DTA-mediated cell death takes a further 24 hours.  
 
Second, although we aimed at depleting 100% of activated CD134-expressing cells, 
this was not achieved either due to inefficiency of DTA-mediated killing or rapid 
replacement of cells, or both. This is to our advantage because it reproduces better the 
deletion of available target cells by HIV in vivo, where only a proportion of them are 
killed. 
 
Finally, the genetic modification we have induced in the mouse genome is in place 
during the entire development of the mice, and therefore does not reproduce the acute 
onset of infection in adults. However it mimics situations of congenital infection.   138
 
4.2. CD4
+ T cell depletion and deficiency: homeostasis and 
function 
The immune system has extraordinary self-regenerating capacity that allows the 
number of immune cells to be restored after serious insults, provided that the cues 
necessary for the maintenance of each subset are present. The proliferative capacity of 
each subset and its ability to self-regenerate are however different. 
 
We show here that despite the fact that CD4
+ T cells are being depleted, the number 
of these cells in lymphoid tissues is not decreased. Furthermore, this depletion leads 
to changes in other immune populations by significantly increasing the numbers of B 
cells and CD8
+ T cells and results in a decrease of the CD4:CD8 ratio. 
 
A decreased CD4:CD8 ratio is also a hallmark of HIV infection. In this case however, 
it reflects not only a similar increase in CD8
+ T cell counts but also a slow and 
progressive decrease in CD4
+ T cell counts.  
 
4.2.1. Memory and regulatory CD4
+ T cells  
In our model, a significant proportion of memory and regulatory CD4
+ T cells are 
depleted. However, the number of memory T cells is unchanged and in lymph nodes 
is even increased, reflecting the powerful capacity for self-renewal of this population. 
In contrast, regulatory T cells are reduced in Tnfrsf4
Cre/+ R26
Dta/+ mice, indicating a 
breakdown in the homeostasis of this subset.  
   139
Regulatory T cells have been shown to divide homeostatically in lymphopenic 
conditions (Annacker et al., 2001; Gavin et al., 2002) and after antigenic stimulation 
(Walker et al., 2003). We analysed this population in search for clues as to why this 
population is not restoring itself in our system. The phenotype of these cells is 
markedly different from those of control mice. An increased proportion of regulatory 
T cells in Tnfrsf4
Cre/+ R26
Dta/+ mice express activation markers such as low levels of 
CD62L and increased CD43, CD44 and CD49b expression. The increased activation 
of the regulatory T cell compartment in Tnfrsf4
Cre/+  R26
Dta/+ mice can be a 
consequence of a vicious cycle between killing of activated cells and elevated 
turnover of the remaining cells in order to replace the lost ones. The results obtained 
with BrdU and Ki67 labelling favour this hypothesis. Another possibility is that the 
regulatory population of Tnfrsf4
Cre/+ R26
Dta/+ mice is composed exclusively of the 
‘memory’ population seen in WT mice (Fisson et al., 2003) due to the depletion in the 
thymus of the ‘naïve’ regulatory T cell population. We have shown that, in the 
thymus, expression of YFP by regulatory T cells was almost as high as in the 
periphery (60% vs 80%), in agreement with other studies that pointed out that 
regulatory T cells are already activated in the thymus. However CD134 is expressed 
preferentially in the ‘memory’ population. In addition, our observation that regulatory 
cells in Tnfrsf4
Cre/+ R26
Dta/+ mice are more activated than the ‘memory’ regulatory 
population of control mice strongly supports the first hypothesis. Therefore, it is 
unlikely that the regulatory population in Tnfrsf4
Cre/+ R26
Dta/+ mice appears activated 
due to selective loss of the ‘naïve’ regulatory subset. 
 
Regulatory T cells from Tnfrsf4
Cre/+  R26
Dta/+ mice show a higher than two fold 
increase in the turnover rate in comparison to control mice, as evaluated by BrdU   140
incorporation and Ki67 staining. The increased homeostatic proliferation is however 
insufficient to compensate for the loss of these cells, indicating that death occurs 
faster than cell proliferation. It is also possible that a fraction of regulatory T cells 
have been generated by conversion of memory CD4
+ T cells rather than by division of 
regulatory T cells (Akbar et al., 2007). 
 
Contrasting with the higher levels of activation and proliferation of regulatory T cells, 
the memory T cell compartment in Tnfrsf4
Cre/+ R26
Dta/+ mice does not show such 
profound changes in their activation profile and turnover rate compared with those in 
control mice. Indeed, except for a small increase in the expression of CD43 and 
CD49b markers and in the production of IFNγ, they are comparable to memory cells 
in control mice. Their proliferation rate as assessed by BrdU incorporation was not 
significantly different when compared to controls and analysis of Ki67 revealed only 
a mild increase. 
 
However, we demonstrated in the mixed bone marrow chimera experiments that 
Tnfrsf4
Cre/+ R26
Dta/+-origin memory cells are killed as efficiently as regulatory T cells.  
 
In normal mice in steady-state conditions, the memory CD4
+ T cell pool contains a 
very high percentage of cells dividing at any one time (40% were labelled by Ki67) 
and consequently an equivalent proportion of cells must die as their absolute numbers 
do not change. Indeed, memory CD4
+ T cells have a much higher turnover rate and 
thus shorter life-span, at the single-cell level, than naïve CD4
+ T cells. 
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This means that the DTA-mediated depletion in memory CD4
+ T cells will probably 
have a minor impact on top of the already high death rate, because many of the cells 
targeted by DTA are pre-destined to die anyway. Thus, it is the difference between 
DTA-mediated killing and normal cell intrinsic death rate that dictates the impact 
DTA has on each population.  
 
4.2.2. Preservation of CD4
+ T cell numbers 
The mechanism responsible for the progressive decline of CD4
+ T cells in HIV 
infection is not completely understood nor is the long time scale of this process, often 
over a period of ten years or longer. One proposed mechanism for the CD4
+ T cell 
loss is that immune activation increases target cell availability and leads to ongoing 
cycles of infection and virus production resulting in depletion of more CD4
+ T cells. 
However, mathematical modelling has shown that if this ‘runaway’ hypothesis were 
correct, then CD4
+ T cells would fall to low levels in a matter of months, not years 
(Yates et al., 2007). Therefore, the slow decline of CD4
+ T cells in HIV infection 
needs to be better understood. 
 
The average time to progress to AIDS is markedly shorter in SIV-infected Indian 
rhesus macaques than in untreated HIV-1 individuals. In contrast, in SIV-infected 
Chinese rhesus macaques the course of infection is slower, thus making them more 
similar to HIV-infected individuals (Ling et al., 2002). Interestingly, in SIV-infected 
Indian rhesus macaques, progression to AIDS is associated with a rapid depletion of 
circulating and mucosal CD4
+CCR5
+ memory T cells (Mattapallil et al., 2004) 
whereas Chinese rhesus macaques experience a relative expansion of the CD4
+CCR5
+ 
pool, the extent of which is clearly associated with markers of disease progression   142
(Monceaux et al., 2007). This is also the case for the asymptomatic phase of HIV-1 
infection where there is an increase in the proportion of CCR5 expressing CD4
+ T 
cells (Ostrowski et al., 1998). Infection with HIV-2 which is characterized by a very 
slow disease progression, is also associated with an increase in the proportion of 
CCR5
+ within the memory /effector CD4
+ T cell pool which correlates with the 
degree of CD4
+ T cell depletion and immune activation (Soares et al., 2006).  
 
Thus, progression to disease in slow SIV progressors  (Chinese rhesus macaques), 
HIV-2 and asymptomatic HIV-1 is associated with a relative increase of CD4
+CCR5
+ 
in the periphery, whereas in the fast SIV progressors (Indian rhesus macaques) 
disease is associated with depletion of the same cells. 
 
Interestingly, in our model, there is a relative increase in effector-memory CD4
+ T 
cells, the same cells that are being killed, similarly to what happens in HIV-1 
infection. Our model is thus a good model for the asymptomatic phase of HIV-1. 
 
CD4
+ T cells in Tnfrsf4
Cre/+  R26
Dta/+ mice, including the memory subset, are 
numerically stable over time, even in aged mice of 8 months of age, which was the 
latest time point analysed. It is therefore interesting to explore the mechanisms 
responsible for the memory CD4
+ T cell preservation in these mice. 
 
Memory CD4
+ T cells can be renewed either by cell division (proliferation) or by 
differentiation of naïve T cells. For naïve T cells to differentiate into memory cells 
they need to be activated and divide. In this process they will become targets for HIV, 
and in our system they will express CD134 and die. This continuous pressure would   143
drain the naïve pool in situations of thymic involution. Thus it is tempting to speculate 
that in our model, the maintenance of a normal thymus contributes to the maintenance 
of the CD4
+ T cell numbers. 
 
In HIV infection, depletion of naïve CD4
+ T cells can sometimes be observed, but 
whether it is critical for the decline of memory CD4
+ T cells is not known. In SIV 
infection of macaques, some studies report depletion of naïve T cells (Nishimura et 
al., 2007), whereas other studies report intact CD4
+ naïve cell compartment (Okoye et 
al., 2007). Observations that thymectomized rhesus macaques do not show significant 
differences in terms of T cell decay or disease progression (Arron et al., 2005), 
suggest that the naïve population is not a major determinant of memory CD4
+ T cell 
homeostasis in chronic SIV infection.  
 
However, the age-associated thymic involution and HIV-mediated thymic inhibition 
are likely to make it more difficult for the thymus to keep up with the constant drain 
on the naïve T cell pool to flow into the memory T cell pool (Douek, 2003). Efficient 
thymopoiesis has been strongly associated with maintenance of circulating CD4
+ T 
cells in slow progressors (Dion et al., 2007) and has also been implicated in a better 
outcome of HIV-2 infection when compared with HIV-1 (Gautier et al., 2007). 
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4.2.3. Immunodeficiency 
Tnfrsf4
Cre/+ R26
Dta/+ mice do not spontaneously develop any opportunistic infections, 
which is not surprising since they are housed in clean facilities, where even mice 
lacking innate (MyD88
-/-) or adaptive (Rag
-/-) immune systems live healthy. However, 
when submitted to experimental infection these mice proved to be immunodeficient. 
Thus, despite having normal numbers of CD4
+ T cells, the accelerated turnover rate or 
the immune activation status of antigen experienced cells compromised their function.  
 
The inability to mount a strong immune response can be due to insufficient precursor 
frequency of one or more of the effector populations. However, this is unlikely to be 
the case for the Tnfrsf4
Cre/+ R26
Dta/+ mice, because naïve CD4
+ or CD8
+ T cells are 
not reduced. The accelerated turnover rate of effector/memory pool is more likely to 
be the cause, since cells respond to pathogens by becoming activated. A primary 
response peaks at ~7 days and by that time we have shown that cells are already 
affected by DTA-mediated killing.  
 
Although a contribution of CD8
+ T cell activation phenotype in the 
immunodeficiency of these mice is possible, we measured immune deficiency by 
specifically assessing CD4
+ T cell function. In the experimental infection with 
Influenza virus, we looked at the production of nAb that is absolutely dependent on 
CD4
+ T cells. In Friend virus infection, we assessed both the production of 
neutralizing antibodies and the control of viremia both of which have been shown to 
be dependent on CD4
+ T cells in the chronic stage of infection, but not on CD8
+ T 
cells (Super et al., 1998). The correlation observed between production of neutralizing 
antibodies and control of infection further support a role of CD4
+ T cells, in the   145
resolution of this infection. Finally, CD4
+ T cells have been shown to be the critical 
subset in controlling Pneumocystis infection but also to be responsible for the 
deleterious effects of the inflammatory response. In this context, it was shown that 
regulatory T cells suppress the CD4
+ T cell mediated pulmonary hyper-inflammation 
in immune deficient mice (Hori et al., 2002). 
 
In untreated HIV infection, there is a progressive loss of immune competence with 
some infections being more likely to occur at higher CD4
+ T cells counts than others. 
For instance, candidiasis and herpes simplex virus, both of which have increased 
incidence among individuals with HIV, can occur even at fairly high CD4
+ T cell 
counts.  Mycobacterium tuberculosis carriers infected with HIV are more likely to 
develop tuberculosis than those without HIV, and this is also not necessarily 
associated to low CD4
+ T cell counts. Bacterial pneumonia, very frequent in HIV-
positive individuals, occurs at all CD4
+ T cell counts, although it becomes more 
frequent as CD4
+ T cell counts go down (Hirschtick et al., 1995). Other infections 
however, develop only when CD4
+ T cell counts drop below a certain threshold: 
Kaposi’s sarcoma, Pneumocystis pneumonia, toxoplasmosis and Cryptococcus, 
Mycobacterium avium complex and cytomegalovirus, all develop at < 250 CD4
+ T 
cells/µl. 
 
Similarly, we find that Tnfrsf4
Cre/+ R26
Dta/+ mice are immune deficient to an array of 
infections, but the degree of deficiency depends on the type of infection and its 
chronicity.   146
 
4.3. Immune activation 
 
4.3.1. Immune activation in HIV 
It has long been recognised that HIV infection is characterized not only by 
immunodeficiency but also by immune activation. In fact, elevated levels of CD38 
expression in CD8
+ T cells were already described in the initial reports of AIDS in 
1981 (Gottlieb et al., 1981; Masur et al., 1981).  
 
Immune activation has recently been proposed as the major driving force behind the 
systemic decline of CD4
+ T cells in HIV infection (Grossman et al., 2006). The fact 
that activation marker expression correlates well with disease progression supports 
this idea (Silvestri and Feinberg, 2003; Sousa et al., 2002; Hazenberg et al., 2003). 
Moreover patients in whom highly active antiretroviral therapy fails to reduce viral 
loads, but who have low levels of T cell activation, show a continuous increase in 
CD4
+ T cells (Hazenberg et al., 2002; Deeks et al., 2002). Conversely, patients with 
high levels of immune activation despite viral load suppression have poor gains in 
CD4
+ T cell counts (Hunt et al., 2003). Additionally, SIV-infected sooty mangabeys 
and African green monkeys do not usually develop AIDS-like disease despite high 
viral loads. Contrary to SIV-infected macaques, they do not display marked immune 
activation (Silvestri et al., 2003; Kornfeld et al., 2005; Sumpter et al., 2007). Another 
piece of evidence comes from studies in the mouse. A transgenic mouse strain 
constitutively expressing the co-stimulatory molecule CD70 on B cells, shows 
persistent CD4
+ and CD8
+ T cell activation leading to excessive generation of   147
effector/memory CD4
+ and CD8
+ T cells and the gradual depletion of naïve CD4
+ and 
CD8
+ T cell pools. Notably, these mice develop lethal immunodeficiency (Tesselaar 
et al., 2003).  
 
4.3.2. Immune activation in Tnfrsf4
Cre/+ R26
Dta/+ mice 
Immune activation in HIV-infected individuals is manifested not only by an increase 
in activation and turnover of immune cells, but also by an enlargement of the lymph 
nodes and by increased serum levels of inflammatory factors. 
 
Tnfrsf4
Cre/+  R26
Dta/+ mice show systemic and dramatic lymphadenopathy. This 
condition occurs in many inflammatory and infectious states and has been proposed to 
be dependent on dendritic cell-mediated endothelial cell proliferation and induction of 
high endothelial venules and consequent recruitment of circulating cells in the lymph 
nodes  (Webster et al., 2006). However, mice lacking regulatory T cells such as 
FoxP3
-/- (Fontenot et al., 2003) or the spontaneous mutant Scurfy (Brunkow et al., 
2001) or mice with an inducible regulatory T cell deficiency (Kim et al., 2007; Lund 
et al., 2008) also show enlarged lymph nodes. Whether this enlargement is the result 
of the generalized inflammatory state of these mice, or is a direct consequence of the 
lack of regulation by regulatory T cells is open to debate. 
 
Interestingly, although Tnfrsf4
Cre/+ R26
Dta/+ mice have a deficit in the regulatory CD4
+ 
T cell compartment, they do not develop the severe pathology which includes wasting 
disease, failure to thrive, and inflammatory, autoimmune and allergic manifestations 
that is common in mice lacking regulatory T cells. Indeed Tnfrsf4
Cre/+ R26
Dta/+ mice 
do not show developmental problems or obvious signs of autoimmunity or   148
inflammation. One obvious difference between Tnfrsf4
Cre/+ R26
Dta/+ and regulatory T 
cell-deficient mice that could explain this finding is that in the latter all regulatory T 
cells are depleted, while in Tnfrsf4
Cre/+ R26
Dta/+ mice depletion is not complete but 
restricted to ~ 40% of these cells. The remaining cells however are activated and 
presumably have a strong suppressive effect. Furthermore, and perhaps more 
importantly, in Tnfrsf4
Cre/+ R26
Dta/+ mice both regulatory and activated/memory cells 
are targeted. In the FoxP3
-/- or the natural mutant Scurfy it has been shown that the 
autoimmunity phenotype depends on a population of FoxP3
-CD4
+ T cells with self-
reactive TCR that act as effectors in the absence of regulation by regulatory T cells 
(Blair et al., 1994). It is thus possible that the effect of DTA depletion on possibly 
pathogenic non-regulatory T cells blocks the development of overt disease in 
Tnfrsf4
Cre/+ R26
Dta/+ mice.  
 
Mice deficient in regulatory T cells have excessive T cell activation and consequent 
excessive secretion of proinflammatory mediators such as TNFα (Kanangat et al., 
1996), IL-13, GM-CSF (Kim et al., 2007) and  CCL2 (MCP-1), CXCL9 and CXCL10  
(Lund et al., 2008). Similarly, Tnfrsf4
Cre/+ R26
Dta/+ mice have increased levels of these 
and other proinflammatory cytokines and chemokines in serum. Cytokines and 
chemokines create complex networks of signals for cells and the increase in specific 
cytokine and chemokines in Tnfrsf4
Cre/+ R26
Dta/+ mice is probably only part of the 
picture, but it is nevertheless the reflection of a systemic increase in activation of the 
immune system. 
 
Interestingly, HIV infection is also associated with increased levels of circulating 
inflammatory chemokines (Reinhart, 2003). Specifically, elevated levels of plasma   149
CXCL9 and CXCL10 have been observed in HIV-infected individuals with stable, 
chronic infection and with advanced disease when compared to uninfected controls 
(Brainard et al., 2007). IL-1α, IL-1β, IL-12 and IFNγ have been shown to be 4 to 12 
times increased in HIV-infected tonsil tissue when compared to uninfected controls, 
and were reduced after 4 weeks of HAART (Andersson et al., 1998). 
 
4.3.2.1. Immune activation of CD8 T cells 
Cellular activation is mostly defined by the expression of markers on the cell surface 
that are indicative of activation and also by increased turnover rate.  
 
In HIV infection the increase in total CD8
+ T cell counts in the asymptomatic period 
is primarily due to an expansion of memory cells (Roederer et al., 1995). In addition, 
CD8
+ T cells express activation markers and have higher turnover rates (Sachsenberg 
et al., 1998) and more recently it has been shown that the increased turnover of CD8
+ 
T cells involves effector-memory cells, while normal levels of turnover are observed 
for both naïve and central memory T cells (Hellerstein et al., 2003). Importantly, 
CD8
+ T cell activation is a better correlate for disease progression than viral loads or 
CD4
+ T cell counts. 
 
We showed that the CD8
+ T cell population in the lymph nodes of Tnfrsf4
Cre/+ 
R26
Dta/+ mice was increased when compared with control mice, and this was also due 
to increased numbers of memory CD8
+ T cells. These cells express lower levels of 
CD62L, which is expressed in central memory but not effector memory CD8
+ T cells, 
and higher levels of CD43 activation marker consistent with a phenotype of 
activated/effector memory CD8
+ T cells. The CD8
+ T cell population of Tnfrsf4
Cre/+   150
R26
Dta/+ mice is thus activated, enriched in effector memory cells and with higher 
turnover rates, similar to the situation in HIV infection. 
 
Causes of immune activation 
Many factors have been proposed to drive immune activation, including HIV itself, 
microbes, cross reactivity to apoptotic cells and regulatory T cell depletion. 
 
HIV 
HIV-1 derived single-stranded RNA sequences have been implicated in the activation 
of the immune system. One way by which microbial products can activate the 
immune system is via interactions with toll-like receptors (TLRs) (Janeway, Jr. and 
Medzhitov, 2002). HIV-derived uridine-rich sequences have been shown to interact 
with TLRs. When CD4
+ and CD8
+ T cells were stimulated with these sequences in 
vitro, they upregulated CD69, a marker of recent activation (Meier et al., 2007). 
However the study did not include data on CD38 or HLA-DR markers, which are the 
activation markers usually reported to be increased in HIV studies. In addition, 
assuming that monkeys have a pattern of TLR expression similar to humans, the same 
activation should occur with SIV. However, natural hosts do not have immune 
activation. In this respect, it has been suggested that plasmacytoid dendritic cells 
(pDCs), the major IFN-α producing cells in response to viral infections, from sooty 
mangabeys stimulated with SIV failed to produce IFN-α, but were however 
responsive to influenza virus. In contrast, pDCs from rhesus macaques, were fully 
responsive to SIV.  (Keystone Symposia, Determinants of Host resistance, 
Succeptibility or Immunopathology to Pathogens: Integrating knowledge from 
experimental models to human disease, 2006. Poster abstract 145, Klucking, S et al,   151
Inneficient production of IFN-α by pDCs is involved in the limited immune activation 
and AIDS-resistance in naturally SIV-infected SMs; Speaker abstract 006, Staprans S 
et al , Host-virus relationships in non-pathogenic SIV infections). 
 
It is thus possible that the differential signalling by TLRs of sooty mangabeys may 
result in attenuated response of the innate system and may explain the low levels of 
immune activation in these animals. Interestingly, another SIV natural host, the 
African green monkey, has been shown to have an early anti-inflammatory response 
in response to SIV infection, by producing high levels of TGF-β and IL-10 which 
could as well explain the lack of immune activation in this species (Kornfeld et al., 
2005). 
 
In any case, a direct effect of viral infection in immune activation can be excluded in 
our virus-free model, indicating that other causes must be responsible for the immune 
activation in Tnfrsf4
Cre/+ R26
Dta/+ mice. 
 
Other microbes 
The drop in CD4
+ T cell counts and the inflammatory conditions occurring during the 
acute phase of HIV infection may favour the reactivation and replication of latent 
forms of CMV and Epstein-Barr virus (EBV) (Papagno et al., 2004). In addition, the 
chronic loss of CD4
+ in the asymptomatic phase of the disease renders the immune 
system less capable of fighting microbes and HIV individuals are more susceptible to 
widespread diseases such as malaria, tuberculosis, pneumonia, etc. This heightened 
exposure to microbes has been proposed to contribute to generalized immune 
activation.   152
 
To address this issue, cells were stimulated in vitro with several TLR ligands. 
Stimulation lead to expression of the activation marker CD38 in CD4
+ and CD8
+ T 
cells but not HLA-DR (Funderburg et al., 2008), suggesting that systemic exposure to 
a number of microbial TLR agonists could drive, at least partly, immune activation in 
HIV. 
 
One way by which microbes can have access to the immune cells is through ‘leaky’ 
mucosas. It has been proposed that the early depletion of CD4
+ T cells from the gut 
mucosa in HIV infection is critical to disease pathogenesis (Brenchley et al., 2006). 
According to this study, the direct cytopathic effects of HIV on CD4
+CCR5
+ T cells 
are the cause of the depletion which in turn compromises the gut mucosa, allowing 
commensal bacteria and/or their products to leak into the circulation by a 
phenomenon known as microbial translocation, which then leads to systemic 
activation. In support of this, plasma levels of lipopolysaccharide (LPS), a component 
of Gram negative bacteria, which can be used as a quantitative indicator of microbial 
translocation, are significantly elevated in individuals with chronic HIV infection and 
AIDS and the same is true for SIV-infected macaques but not for sooty mangabeys. 
However, people with acute/early HIV infection did not show elevated LPS levels. 
This could be explained by the presence of anti-LPS antibodies which wane over time 
as individuals with HIV become more immunodeficient. 
 
It has been argued that the depletion of CD4
+ T cells from the gut is unlikely to be 
very important because the majority of these cells are short-lived effectors and the 
ability to replenish the gut is maintained (Grossman et al., 2006). Supporting this   153
argument is the fact that a similar depletion occurs in SIV-infected sooty mangabeys 
and African green monkeys, but these animals almost never develop 
immunodeficiency or immune activation (Gordon et al., 2007; Pandrea et al., 2007). 
 
More recently it has been shown that TH17 cells, a recently described CD4
+ T cell 
subset that produces IL-17 and IL-22 and is involved in antimicrobial immunity at 
mucosal surfaces (Steinman, 2007), express CCR5 and are preferentially lost from the 
gastrointestinal tract of HIV-infected individuals and SIV-infected rhesus macaques 
but are maintained in SIV-infected sooty mangabeys (Brenchley et al., 2008; 
Raffatellu et al., 2008). Thus, depletion of TH17 cells can be the critical mechanism to 
explain loss of bacteria control and microbial translocation in pathogenic lentiviral 
infections. 
 
Although histological analysis performed on Tnfrsf4
Cre/+ R26
Dta/+ mice did not reveal 
alterations in the morphology or cellular composition of the intestinal mucosa, we 
cannot definitely exclude that a small degree of microbial translocation is occurring in 
the Tnfrsf4
Cre/+ R26
Dta/+ mice and that this is the mechanism involved in the CD8
+ T 
cell activation in these mice.  
 
We do not favour this possibility because in a mouse model of severe microbial 
translocation, the Ikbkg
fl/- Vil-Cre mice, the major immune compartment affected is 
the monocytic compartment rather than CD8
+ T cells. However to rule out a role of 
microbial translocation in the Tnfrsf4
Cre/+  R26
Dta/+ mice, we are crossing them to 
MyD88
-/- mice. MyD88 is an adaptor molecule essential for most TLR-mediated 
induction of inflammatory cytokines (Takeda and Akira, 2003). Although microbes   154
may trigger immune cells through pathways other than TLRs (Robinson et al., 2006), 
and a few TLRs can signal through Myd88-independent pathways (Kenny and 
O'Neill, 2008), MyD88 seems nevertheless to be essential for microbial translocation 
induced pathology, as evidenced by the fact that Ikbkg
fl/-  Vil-Cre mice rendered 
MyD88 deficient are free of any signs of disease. Ultimately, this issue can only be 
resolved by generating germ-free Tnfrsf4
Cre/+ R26
Dta/+ mice.  
 
Apoptotic/necrotic cells 
The continuous turnover of apoptotic cells has been proposed to generate fragments of 
cellular proteins cleaved by caspases which are capable of priming self-reactive CD8
+ 
T cells. In HIV infection, the magnitude of the CD8
+ T cell response directed against 
this apoptosis-derived peptides correlates with the decline in CD4
+ T cell counts 
suggesting that these self-reactive CD8
+ T cells can contribute to the systemic chronic 
immune activation (Rawson et al., 2007).  
 
In  Tnfrsf4
Cre/+  R26
Dta/+ mice this could be a potential cause of chronic immune 
activation, since in this system there is a continuous deletion of CD4
+ T cells by DTA-
mediated apoptosis. However, in mixed bone marrow chimeras, where there is a 
continuous depletion of CD4
+ T cells, there is no evidence of CD8
+ T cell activation. 
Thus, it is unlikely that this mechanism is involved in the CD8
+ T cell immune 
activation seen in Tnfrsf4
Cre/+ R26
Dta/+ mice. 
 
Regulatory T cells  
Lack of immunosuppression by progressive loss of regulatory T cells during HIV 
infection has also been proposed as a possible mechanism of chronic immune   155
activation. Many studies have addressed the role of regulatory T cells in HIV and SIV 
infection but there is still controversy as to whether they are beneficial or detrimental. 
Although it is clear that regulatory T cells can be infected and killed by HIV (Oswald-
Richter et al., 2004; Antons et al., 2008), there is no consensus as to whether they are 
increased (Weiss et al., 2004; Tsunemi et al., 2005; Tsunemi et al., 2005; Kinter et al., 
2004; Montes et al., 2006), decreased (Oswald-Richter et al., 2004; Apoil et al., 2005) 
or unchanged (Aandahl et al., 2004) in the course of HIV infection. One of the 
reasons that could explain this discrepancy is the fact that some studies present data as 
proportion of CD4
+ T cells rather than absolute numbers. Since total CD4
+ T cells are 
diminished in HIV infection, the expression of regulatory T cells as percentage of 
CD4
+ T cells will not reflect their loss. Indeed one study reported decreased absolute 
numbers but increased numbers of regulatory T cells as percentage of CD4
+ T cells 
(Eggena et al., 2005). The inconsistency in the results may also be partly explained by 
the markers used to define this subset. Many studies have distinguished regulatory 
cells by the expression of CD25, but activated effector cells also express this marker 
transiently. Other studies have classified regulatory T cells according to the level of 
CD25 expression which has been shown to roughly divide activated T cells (low 
CD25 expression) from regulatory T cells (high CD25 expression) in the peripheral 
blood of healthy subjects (Baecher-Allan et al., 2001). Indeed, Foxp3 is expressed in 
more than 95% of peripheral blood CD4
+CD25
high but in only 35% of CD4
+CD25
int 
(Ziegler, 2006) supporting the notion that most regulatory T cells  would be included 
in the fraction of CD4
+ T cells  expressing high intensity of CD25. Another important 
point to consider is that changes observed in peripheral blood are not representative of 
what is happening in the lymphoid tissues or intestinal mucosa but rather are the 
consequence of redistribution of regulatory T cells to tissues with active replication   156
(Epple et al., 2006; Nilsson et al., 2006; Andersson et al., 2005; Kinter et al., 2007). 
Moreover, the stage of disease at the time of sampling can also contribute to the 
disparity. Finally, it should be pointed out that classification of cells according to 
surface markers not necessarily correlates with functional activity of these cells, and it 
has been shown that functional regulatory T cells decrease with disease progression 
and increasing viral loads (Kinter et al., 2004).  
 
Considering all this, it is maybe not surprising that the role of regulatory T cells 
during HIV infection and pathogenesis is controversial. While some studies point to a 
beneficial role of regulatory T cells in limiting the overall immune activation (Kinter 
et al., 2004; Oswald-Richter et al., 2004; Tsunemi et al., 2005; Apoil et al., 2005; 
Eggena et al., 2005; Baker et al., 2007; Chase et al., 2008), others suggest that these 
cells are detrimental by impairing T cell responses and thus facilitating HIV 
persistence (Weiss et al., 2004; Aandahl et al., 2004; Andersson et al., 2005; Nilsson 
et al., 2006; Lim et al., 2007).  
 
Studies in non-human primates have not been able to clarify this issue. Some studies 
point for a detrimental role (Boasso et al., 2007; Estes et al., 2006; Hartigan-O'Connor 
et al., 2007) while others point to a beneficial role (Li et al., 2005; Pereira et al., 2007; 
Kornfeld et al., 2005; Chase et al., 2007) of regulatory T cells in the control of SIV 
infection. 
 
The decreased number of regulatory T cells in Tnfrsf4
Cre/+ R26
Dta/+ mice could imply 
less regulation and consequently activation of the CD8
+ population. If regulatory T 
cells are responsible for the CD8
+ T cells phenotype of Tnfrsf4
Cre/+ R26
Dta/+ mice,   157
then transfer of WT regulatory T cells should be able to revert the phenotype. Indeed, 
when we transferred WT regulatory T cells into Tnfrsf4
Cre/+ R26
Dta/+ and control mice 
we observed first that these cells failed to proliferate when transferred to Tnfrsf4
Cre/+ 
R26
+/+ full recipient mice, but did so in Tnfrsf4
Cre/+ R26
Dta/+ recipients, confirming 
that these cells are capable of homeostatic proliferation in regulatory T cells- 
lymphopenic hosts (Annacker et al., 2001; Gavin et al., 2002). Second, the levels of 
CD8
+ memory cells in the blood started decreasing at 1 week and reached wild-type 
levels by week 3 which were maintained 4 weeks later. This was also true for the 
activated/effector memory CD8
+ T cells which reach percentages similar to control 
mice in lymphoid tissues. Thus, the immune activation seen in Tnfrsf4
Cre/+ R26
Dta/+ 
mice is a consequence of the deficit in the regulatory T cell population. 
 
Some papers have implicated a role for CD25 cells on the suppression of memory 
CD8
+ T cells proliferation and activation (Murakami et al., 2002; Piccirillo and 
Shevach, 2001; Camara et al., 2003)  while others pointed to a role of regulatory T 
cells in preventing CD8
+ T cell–mediated autoimmunity (Poitrasson-Riviere et al., 
2008). Regulatory cells use multiple mechanisms to mediate their suppressive 
function, and specifically for what concerns their effect on CD8
+ T cells, the 
following mechanisms have been proposed: consumption of IL-2 (Murakami et al., 
2002), suppression of DC maturation and function (Kim et al., 2007) and production 
of TGFβ (Mempel et al., 2006). 
 
If immune activation in HIV and SIV is due to a progressive depletion of regulatory T 
cells, how can it be explained that non pathogenic SIV infected animals do not show 
immune activation? It is generally accepted that regulatory T cells are depleted during   158
HIV and SIV infection although to our knowledge there are no studies addressing if 
regulatory T cells from non-human primates are infected and killed by SIV in non-
pathogenic natural infections. Interestingly, it has recently been show that TH17 are 
depleted in pathogenic, but not in non-pathogenic SIV infections (Raffatellu et al., 
2008; Brenchley et al., 2008). We could speculate that the same is true for regulatory 
T cells. It could be that regulatory T cells in natural hosts of SIV are more resistant to 
infection, perhaps due to reduced levels of CCR5 expression, or, to virus-mediated 
killing. Alternatively, it could be that regulatory T cells in these hosts are replenished 
more efficiently than those in humans. Indeed, it has been shown that SIV infection 
influences the level and function of regulatory T cells in rhesus macaques but not 
sooty mangabeys (Pereira et al., 2007). 
 
 
4.3.2.2. B cells 
Polyclonal hypergammaglobulinemia is a characteristic of chronic inflammatory 
conditions such as persisting viral infections and autoimmune diseases (Hunziker et 
al., 2003) and together with B cell hyperactivation is one of the hallmarks of HIV-1 
infection. However we did not observe any evidence of B cell activation other than an 
apparently innocuous increase in the number of germinal centre B cells in Tnfrsf4
Cre/+ 
R26
Dta/+ mice, suggesting that CD4
+ depletion per se in not responsible or is not 
sufficient to activate this population. 
 
Consistent with this hypothesis, a recent study has involved the HIV-1 Nef protein as 
the factor responsible for the B lymphocyte hyperactivation and 
hypergammaglobulinemia observed in HIV-1 patients (Swingler et al., 2008). The   159
study shows that Nef activates ferritin production in macrophages which is necessary 
and sufficient for the above mentioned effects on B cells. In HIV-1 infected 
individuals, plasma viral RNA load correlates well with ferritin and immunoglobulin 
levels but not with immune activation. In addition, similar correlations were observed 
in mice transgenic for HIV-1 Nef suggesting that the elevated levels of ferritin and 
consequent B cell dysfunction are a direct result of Nef expression due to viral 
replication and excludes a role of immune activation in the phenotype of B cells 
(Swingler et al., 2008). 
 
Why are then B cell numbers increased in Tnfrsf4
Cre/+ R26
Dta/+ mice? One possibility 
is the lack of negative regulation by regulatory T cells. In a study where regulatory T 
cells were depleted, B cells were shown to be increased  by 3 fold in the spleen and 
1.8 fold in the lymph nodes (Kim et al., 2007) but this was most likely due to the 
generalized inflammatory state. The increase in B cell numbers could thus be an 
indirect consequence of the increase in lymph nodes size that is regulated by DCs 
(Webster et al., 2006). 
 
 
4.3.2.3. Macrophages 
Cells of the monocyte/macrophage lineage disseminate the virus and serve as 
ubiquitous reservoirs for HIV-1. Certain tissue-specific macrophage populations have 
been shown to be increased in numbers and activation state in HIV-1 infection (Lee et 
al., 2003; Evans and Wansbrough-Jones, 1996) although this has not been confirmed 
at the systemic level. Macrophage numbers are thought to be stable during HIV-1 
infection and to be a significant source of virus production when CD4
+ T cell counts   160
are low (Orenstein et al., 1997). Similarly, infection of rhesus macaques with a 
chimeric HIV/SIV was associated with a gradual increase in macrophages over time, 
which were responsible for virus production at the time of CD4
+ T cell loss (Igarashi 
et al., 2001). 
 
Our analysis of Tnfrsf4
Cre/+ R26
Dta/+ mice did not reveal overt macrophage activation. 
The small increase in numbers of macrophages in lymph nodes of these mice is 
proportional to the increase in total cells and probably just reflects the fact that lymph 
nodes are enlarged. In contrast, macrophage numbers were dramatically elevated in 
mice with primary microbial translocation through the intestinal mucosa. It thus 
appears that numbers of macrophages are more responsive to microbial exposure than 
regulatory T cell function. Interestingly, increased viremia often seen during 
opportunistic infection of HIV-1 infected individuals has been attributed to 
macrophage activation (Orenstein et al., 1997). 
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5. Concluding remarks 
The CD4
+ T cell compartment is complex and heterogeneous, comprising several 
lineages and maturation/differentiation states that differ in their life-spans, capacity 
for self-renewal, and functional properties in the immune system. At least three 
distinct major subsets can be identified: naïve, memory and regulatory T cells. 
Memory and the regulatory subsets are heterogeneous. Memory cells can be classified 
as TEM and TCM while regulatory T cells can also be divided in naïve and 
effector/memory. Additionally, a fourth population of effector cells is transiently 
produced in the course of an immune response. 
 
These subsets are differentially targeted by HIV-1 infection and other 
immunodeficiency viruses. The fact that all retroviruses capable of causing 
immunodeficiency target the same cells indicates a central role of these cells in the 
pathogenesis of immunodeficiency disease. To test this hypothesis, our approach was 
to target the same cells in a virus-free murine model and assess whether specific 
depletion of these populations could cause disease. We were able to show a causal 
link between deletion of these cells and disease. Specifically, we were able to show 
that regulatory CD4
+ T cell killing leads to generalized immune activation and that 
effector/memory CD4
+ T cell killing results in immunodeficiency. Thus, the 
complexity of the dysfunction in HIV is a pure reflexion of the functional 
heterogeneity of its targets. 
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